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 ABSTRACT 
Many diseases, for example Alzheimer’s disease and type 1 
diabetes, alter lipid metabolism. The analysis of serum lipid 
composition by conventional methods is time-consuming and 
requires a combination of several analytical techniques such as 
thin-layer chromatography, gas chromatography, and high-
performance liquid chromatography. Nuclear magnetic 
resonance (NMR) spectroscopy has become an alternative 
method that offers a rapid analysis of serum lipids requiring 
only a little sample preparation. 
In the present thesis, 1H NMR-based protocols for the 
analysis of serum lipids were developed and applied to clinical 
studies. The developed extraction and quantification protocol 
allows processing of about 100 samples per day. The protocol 
was applied to two clinical studies. The results from a study 
involving patients with mild cognitive impairment indicated 
that a low relative amount of ω-3 fatty acids is related to mild 
cognitive impairment. Another study revealed the association 
between sphingomyelin and kidney disease in type 1 diabetic 
patients. In addition, an NMR-based oxidation assay for serum 
was developed and applied to a dietary intervention study. The 
NMR assay was shown to be more sensitive than the commonly 
used spectrophotometric assay. 
A part of the thesis was to perform quantum mechanical 
spectral analyses for short n-alkanes. It was proved that the 
proportion of the trans conformations increases when the 
hydrocarbon chain is lengthened, and the chemical environment 
has only a small effect on the conformational equilibrium. 
It can be concluded that the developed protocols for serum 
lipid analyses provide valuable information about the lipid 
components of serum, as well as the oxidation susceptibility of 
serum lipids. 
National Library of Medicine Classification: QU 25, QU 85, QY 465, 
WH 400 
Medical Subject Headings: Lipids/analysis; Serum; Oxidation-Reduction; 
Magnetic Resonance Spectroscopy; Mild Cognitive Impairment/diagnosis; 
Fatty Acids, Omega-3, Sphingomyelins; Diabetes Mellitus, Type 1; Alkanes; 
Molecular Conformation 
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1 Review of the literature 
1.1 STRUCTURE OF LIPIDS 
There is a variety of biological lipids, and their common 
character is their insolubility in water (Nelson & Cox 2000). 
Lipids can be divided into eight categories including fatty acyls, 
glycerolipids, glycerophospholipids, sphingolipids, sterol lipids, 
prenol lipids, saccharolipids, and polyketides (Fahy et al. 2005). 
This thesis concentrates on the serum lipids, and thus, the three 
latter groups are not discussed. 
1.1.1 Fatty acyls 
Fatty acyls, or commonly fatty acids (FAs), are structurally the 
simplest lipids, and they are basic elements of many lipid 
groups. Natural FAs have hydrocarbon chains varying in length 
from 14 to 24 carbon atoms (Hu et al. 2009). These FAs have 
usually even number of carbon atoms in an unbranched chain 
(Otieno & Mwongela 2008). FAs can be either saturated (no 
double bonds) or unsaturated (1 to 6 double bonds) (Hu et al. 
2009). The double bonds of polyunsaturated FAs (PUFAs) are 
separated by a methylene group (=CH-CH2-CH=), and 
conjugated double bonds are normally not present in natural 
PUFAs. In naturally occurring unsaturated FAs, the double 
bonds are usually in the cis configuration (Ratnayake & Galli 
2009). 
The nomenclature of FAs indicates the chain length and the 
number of double bonds (Nelson & Cox 2000). For example, 18-
carbon linoleic acid with two double bonds is named as 18:2. 
The positions of double bonds can be reported in two ways. 
Firstly, the carbons where the double bonds are located are 
counted by starting from the carbonyl carbon and they are 
specified by superscript numbers following delta (Δ) (Ruiz-
Rodriguez et al. 2010). E.g. for linoleic acid, 18:2(Δ9,12). Secondly, 
20   
 
it is possible to use n-x, or ω-x nomenclature, where the first 
double bond is located at the xth carbon counting from the 
terminal methyl carbon of the FA molecule (Figure 1) (Ruiz-
Rodriguez et al. 2010). Common names and structures of 
different types of FAs found in human serum are shown in 
Figure 1. 
 
 
 
Figure 1. Common names and structures of different types of fatty acids found in 
human serum (Assies et al. 2010). DGLA, dihomo-γ-linolenic acid; DHA, 
docosahexaenoic acid; DPA, docosapentaenoic acid; EPA, eicosapentaenoic acid; 
MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid 
1.1.2 Glycerolipids 
Glycerolipids are compounds in which one, two or three FAs are 
attached to a glycerol molecule, and they are called mono- 
(MAG), di- (DAG), or triacylglycerides (TAG) (Figure 2), 
respectively. Glycerolipids have various isomers since FAs can 
be attached in many different ways to sn-1, sn-2, and sn-3 
positions of glycerol backbone (Hu et al. 2009). Usually, the FAs 
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attached to sn-1 carbon are saturated and those in sn-2 and sn-3 
positions are unsaturated (Karantonis et al. 2009). 
 
 
 
Figure 2. Basic structures of monoacylglyceride (A), diacylglyceride (B) and 
triacylglyceride (C). R1, R2, and R3 are hydrocarbon chains of fatty acid molecules. 
Three carbon atoms of the glycerol molecule are designated as sn-1, sn-2, and sn-3. 
Fatty acid chains in monoacylglyceride and diacylglyceride can be also in other 
positions than shown in structures (A) and (B). 
1.1.3 Glycerophospholipids 
Glycerophospholipids (or phosphoglycerides) contain two FAs 
which are attached via an ester linkage to the sn-1 and sn-2 
positions of glycerol backbone, and a highly polar or charged 
group that is attached through a phosphodiester linkage to the 
sn-3 position (Figure 3A,B) (Hu et al. 2009). 
Glycerophospholipids can be further subdivided based on the 
type of bond that links the FA chain to the sn-1 position (Figure 
3C). Linkages can be ester, vinyl ether or alkyl ether that lead to 
phosphatidyl, plasmenyl, and plasmanyl subclasses, 
respectively (Figure 3C) (Peterson & Cummings 2006). At the 
sn-2 position there is always an ester bond, and 
monounsaturated or polyunsaturated FAs are preferred 
(Hodson et al. 2008). Essential ω-6 and ω-3 PUFAs are also 
preferentially stored in sn-2 position, from which they can be 
specifically and rapidly released by phospholipase A-2 (PLA2). 
Saturated (SFAs) and monounsaturated (MUFAs) FAs 
predominate at the sn-1 position (Leaf 2001). Also lyso-
glycerolipids, where one hydroxyl group at the sn-1 or sn-2 
position of the glycerol backbone is intact and the other is 
esterified to FA, belong to the group of glycerophospholipids 
(Hu et al. 2009). 
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Glycerophospholipids are named as derivatives of the parent 
compound phosphatidic acid, according to the polar alcohol in 
the head group (Nelson & Cox 2000). For example, 
phosphatidylcholine (PC) and phosphatidylserine (PS) have 
choline and serine as their polar head groups, respectively. 
 
 
 
Figure 3. Basic structure of a glycerophospholipid (A) and structures of various polar 
head groups (B) that are attached to the phosphate group at the sn-3 position of the 
glycerol backbone (Nelson & Cox 2000; Peterson & Cummings 2006; Hu et al. 2009). 
Glycerophospholipids can be subdivided into phosphatidyl, plasmenyl, and plasmanyl 
subclasses depending on the linkage at the sn-1 position (C) (Peterson & Cummings 
2006; Hu et al. 2009). R1 and R2 are hydrocarbon chains of fatty acid molecules. 
1.1.4 Sphingolipids 
Sphingolipids consist of sphingosine or one of its derivatives, 
one long-chain FA, and a polar head group that is attached 
either by a glycosidic or a phosphodiester linkage. Carbons C-1, 
C-2, and C-3 of the sphingosine molecule are structurally 
analogous to the three carbons of glycerol in 
glycerophospholipids (Figure 4) (Nelson & Cox 2000). Ceramide 
is the structural parent of all sphingolipids, and it has one FA 
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attached to the NH2 group of a sphingosine molecule through 
an amide linkage (Figure 4) (Hu et al. 2009). 
Sphingolipids can be divided into three subclasses: 
sphingomyelins (SMs), glycosphingolipids, and gangliosides 
(Fuller 2010). Sphingomyelins have a phosphocholine or 
phosphoethanolamine attached via an ether linkage to the 
1-hydroxy group of a ceramide, and thus, belong together with 
glycerophospholipids to the group of phospholipids (PLs) 
(Nelson & Cox 2000). Glycosphingolipids contain one or more 
sugar molecules attached through a β-glycosidic bond to the 
ceramide structure (Ratnayake & Galli 2009). Gangliosides are 
the most complex group of sphingolipids and their polar head 
groups include at least three sugar molecules, of which one 
must be sialic acid (Fuller 2010). 
 
 
 
Figure 4. Basic structure of sphingolipids and the structures of two important serum 
sphingolipids, ceramide and sphingomyelin. 
1.1.5 Sterol lipids 
The characteristic structure of sterol lipids is the steroid nucleus 
consisting of four fused rings, three with six carbons and one 
with five (Figure 5). The steroid nucleus is relatively rigid 
whereas the alkyl side chain is flexible (Nelson & Cox 2000). 
Cholesterol is the most common sterol in human serum, and it is 
present as free (unesterified) cholesterol or as cholesteryl esters 
(CEs) (Quehenberger & Dennis 2011). Other examples of sterol 
lipids existing in serum are lathosterol, desmosterol, and 7-
dehydrocholesterol but they are present only in small amounts 
(Quehenberger et al. 2010). 
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Figure 5. A structure of 
unesterified cholesterol with 
numbering of the carbon atoms. 
Polar hydroxyl group at C-3 can 
be esterified with a fatty acid 
yielding a cholesteryl ester. 
 
 
 
1.2 SERUM LIPIDS 
The whole blood is comprised of plasma (54% by volume) and 
various types of circulating cells (46% by volume), mainly 
erythrocytes (Hodson et al. 2008). Plasma consists of water (over 
90%), small metabolites, electrolytes, lipids, and various 
proteins including fibrinogens, albumins, and globulins (Ala-
Korpela 1995). The majority of plasma FAs are esterified in 
many lipid classes such as PLs, TAGs, and CEs, which are 
components of lipoproteins (Risé et al. 2007). To prepare plasma 
from whole blood sample, an anticoagulant (e.g. EDTA; 
ethylenediaminetetraacetic acid or heparin) needs to be added 
prior to the removal of blood cells. Serum is obtained when 
blood is allowed to clot and the clot is removed. Thus, serum 
lacks fibrinogens and related coagulation factors, as well as 
blood cells (Yu et al. 2011). Both serum and plasma can be used 
for lipid profiling studies, but for simplicity, mainly the term 
serum is used in this thesis. 
1.2.1 Structure and function of lipoproteins 
The main function of lipoproteins is to transport water-insoluble 
lipids in biological fluids (Kontush & Chapman 2010). 
Lipoproteins are composed of specific carrier proteins called 
apolipoproteins and varying amounts of TAGs, PLs, and free 
and esterified cholesterol (Nelson & Cox 2000). Lipoproteins 
contain also small amounts of fat-soluble antioxidants, such as 
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α-tocopherol and β-carotene (Ala-Korpela 1995). 
Apolipoproteins are characteristically distributed in the 
lipoprotein classes (Table 1), and they target lipoproteins to 
specific tissues or activate enzymes that act on lipoproteins (Ala-
Korpela 1995; Nelson & Cox 2000). 
Lipoprotein particles can be divided into five main classes 
(Table 1); chylomicrons, very-low-density lipoproteins (VLDLs), 
intermediate-density lipoproteins (IDLs), low-density 
lipoproteins (LDLs), and high-density lipoproteins (HDLs) on 
the grounds of amounts of protein and lipids they contain (Ala-
Korpela 1995). Many of these groups can be further divided into 
several subpopulations based on the particle sizes or densities 
(Suna et al. 2007; Inouye et al. 2010). Hydrophobic TAGs and 
CEs are mainly located in the core of the lipoprotein particles, 
and hydrophilic PLs at the surface (Nelson & Cox 2000). 
 
Table 1. Densities, radiuses, and main apolipoproteins of the human plasma 
lipoproteins (Ordovas 2003; Lusis & Pajukanta 2008; Vergès 2009a). 
 
Lipoprotein Density 
(g/ml) 
Diameter 
(nm) 
Apolipoproteins 
Chylomicrons <0.95 80–500 apoB-48, apoCs, apoE 
VLDL 0.95–1.006 30–80 apoB-100, apoCs, apoE 
IDL 1.006–1.019 25–35 apoB-100, apoE 
LDL 1.019–1.063 18–28 apoB-100 
HDL 1.063–1.210 5–12 apoAI–II, apoCs, apoE 
VLDL, very-low-density lipoprotein; IDL, intermediate-density lipoprotein; LDL, 
low-density lipoprotein; HDL, high-density lipoprotein 
 
Chylomicrons and VLDL particles contain a high proportion 
of TAGs and their function is to transport dietary 
(chylomicrons) or endogenously synthesized (VLDLs) TAGs to 
peripheral tissues (Ordovas 2003). IDLs transport endogenous 
TAGs and cholesterol to tissues and are precursors of LDL 
particles (Daniels et al. 2009). About half of the contents of LDL 
particles is cholesterol, and the function of LDL is to transport 
cholesterol to extrahepatic tissues that require extracellular 
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cholesterol (German et al. 2006; Daniels et al. 2009). The 
important function of HDL particles is the reverse cholesterol 
transport from extrahepatic tissues to liver (Ala-Korpela 1995; 
German et al. 2006). 
1.2.2 Lipid composition of serum 
The FA composition of diet affects physiological and 
pathophysiological processes in the body, such as gene 
expression, membrane properties, and energy expenditure 
(Vessby et al. 2002). The total FA pool of serum reflects both 
dietary intake and endogenous turnover, and it is composed of a 
mixture of all serum lipid fractions that contain FAs (Glaser et 
al. 2010). The most common FAs of serum are linoleic (18:2 ω-6), 
palmitic (16:0), and oleic (18:1 ω-9) acids (Table 2) (Hodson et al. 
2008; Glaser et al. 2010). Approximately 35% of serum FAs are 
saturated, 25% are monounsaturated, and 40% are 
polyunsaturated (Assies et al. 2010). 
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Table 2. Concentrations (µmol/l) and relative amounts (mol%) of serum fatty acids 
(FAs). The concentrations are expressed as means ± standard deviations from 65 
samples of healthy human subjects (Assies et al. 2010). 
 
FA c(µmol/l) mol%   FA c(µmol/l) mol%
18:3 ω-3 63±40 0.61   16:1 ω-9 42±15 0.41
18:4 ω-3 1.5±1.9 0.01   18:1 ω-9 1975±722 19.05
20:5 ω-3 67±44 0.65   20:1 ω-9 14±6 0.14
22:5 ω-3 34±11 0.33   22:1 ω-9 12±8 0.12
22:6 ω-3 130±53 1.25   24:1 ω-9 64±20 0.62
18:2 ω-6 3040±685 29.32   20:3 ω-9 10±5 0.10
18:3 ω-6 47±20 0.45   14:0 146±74 1.41
20:2 ω-6 19±10 0.18   15:0 30±9 0.29
20:3 ω-6 156±94 1.50   16:0 2651±707 25.57
20:4 ω-6 554±165 5.34   18:0 741±174 7.15
22:4 ω-6 14±5 0.14   20:0 25.5±6.1 0.25
22:5 ω-6 9±4 0.09   22:0 58±12 0.56
14:1 ω-5 8.8±7.5 0.08   24:0 38±8 0.37
16:1 ω-7 242±124 2.33   SFAs 3660±942 35.30
18:1 ω-7 163±46 1.57   MUFAs 2527±881 24.37
20:1 ω-7 13±7 0.13   PUFAs 4145±837 39.98
MUFA, monounsaturated FA; PUFA, polyunsaturated FA; SFA, saturated FA 
 
Approximately half of the serum FAs are in the TAG fraction 
(Hodson et al. 2008; Kotronen et al. 2010). Most of the TAG 
molecules are attached to VLDL particles in fasting serum, and 
they contain mainly oleic, palmitic, and linoleic acids (Table 3). 
The FA content of serum TAGs reflects a short-term dietary 
intake (last few meals) of FAs (Zeleniuch-Jacquotte et al. 2000; 
Hodson et al. 2008). The long-term qualitative dietary intake of 
FAs is seen from the FA composition of stored TAGs in adipose 
tissue (Ogura et al. 2010). 
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Table 3. Fatty acid composition in mol% (mol/100 mol total fatty acids) in different 
serum fractions (Hodson et al. 2008). For clarity, standard errors are not shown, but 
are within 5 and 15 mol% units for the most abundant fatty acids, and up to 3 mol% 
units for the fatty acids present in lower amounts. 
 
Fatty acid Abbreviation TAG PL CE FFA
myristic acid 14:0 3.3 0.5 0.8 3.0
palmitic acid 16:0 29.5 31.2 13.6 28.3
stearic acid 18:0 4.5 14.3 1.3 12.5
palmitoleic acid 16:1 ω-7 5.1 1.0 4.0 4.1
oleic acid 18:1 ω-9 37.7 10.1 19.3 32.7
linoleic acid 18:2 ω-6 15.0 21.9 52.0 13.5
DGLA 20:3 ω-6 0.2 2.4 0.5 0.1
arachidonic acid 20:4 ω-6 0.8 8.3 5.1 1.2
adrenic acid 22:4 ω-6 0.0 0.3 0.0 0.0
α-linolenic acid 18:3 ω-3 0.9 0.2 0.6 0.9
EPA 20:5 ω-3 0.1 1.0 0.7 0.1
DPA 22:5 ω-3 0.0 0.7 0.0 0.1
DHA 22:6 ω-3 0.4 3.3 0.4 0.4
CE, cholesteryl ester; DGLA, dihomo-γ-linolenic acid; DHA, docosahexaenoic acid; 
DPA, docosapentaenoic acid; EPA, eicosapentaenoic acid; FFA, free fatty acid; PL, 
phospholipid; TAG, triacylglyceride 
 
Concentrations of selected glycerophospholipids and 
sphingolipids in serum are shown in Table 4, and it can be seen 
that phosphatidylcholine is the most abundant phospholipid. 
The most abundant FAs in serum PLs include palmitic and 
linoleic acids (Table 3). The FA composition of serum PLs 
reflects medium-term (weeks to months) dietary intake of FAs 
(Zeleniuch-Jacquotte et al. 2000; Hodson et al. 2008). Also the PL 
fraction of the erythrocyte membrane mirrors medium-term 
dietary intake of FAs (Patel et al. 2010). 
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Table 4. Total serum concentrations (µM) of selected glycerophospholipids and 
sphingolipids (Wiesner et al. 2009). 
 
Lipid Concentration (µM)
phosphatidylcholine 1986 ± 727 
lysophosphatidylcholine 330 ± 168 
phosphatidylethanolamine 35.6 ± 20.8 
phosphatidylethanolamine- 
based plasmalogen 
31.9 ± 13.9 
sphingomyelin 415 ± 141 
ceramide 8.1 ± 3.4 
 
About two thirds of serum cholesterol is in esterified form, 
and approximately half of the CEs contain linoleic acid (Table 3). 
The benefit of the high amount of unsaturated FAs bound to 
cholesterol may be that they increase the fluidity of the molecule 
(Hodson et al. 2008). The FA composition of serum CEs mirrors 
medium-term dietary intake of FAs, as well as endogenous FA 
metabolism (Zeleniuch-Jacquotte et al. 2000; Kawashima et al. 
2009). 
The lowest amount of FAs, 6% or less, are as free fatty acids 
(FFAs) (Hodson et al. 2008). FFAs are very hydrophobic and 
generally toxic to cells, and therefore their concentrations in 
serum are kept at low nanomolar or micromolar range. About 
99.9% of FFAs in serum are bound to proteins, mainly albumin 
(Leaf 2001). Oleic and palmitic acids are the most abundant 
FFAs in serum (Table 3). 
Serum contains also low amounts of trans fatty acids (TFAs) 
that are obtained from diet. TFAs are produced during the bio-
hydrogenation of PUFAs by ruminant animals or during the 
partial hydrogenation of vegetable oils (Gebauer et al. 2007; 
Mensink & Nestel 2009). Both of these mechanisms yield several 
different geometrical and positional TFA isomers of which trans 
octadecaenoic acids (18:1t) are the predominant products 
(Weggemans et al. 2004). Vaccenic acid (18:1 ω-11t) 
predominates in ruminant fat and elaidic acid (18:1 ω-9t) is the 
major TFA produced by industrial hydrogenation (Weggemans 
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et al. 2004; Gebauer et al. 2007; Thompson et al. 2011). Long-
chain polyunsaturated TFAs, trans octadecadienoic acids 
(18:2c/t, 18:2t/t), and trans octadecatrienoic acids (18:3c/t) are 
produced in smaller amounts (Weggemans et al. 2004). The 
consumption of TFAs is advised to be kept as low as possible 
since some studies have shown that TFAs can increase the 
amount of LDL cholesterol and decrease HDL cholesterol 
(Mensink 2005; Ascherio 2006). 
There are also small amounts of FAs with conjugated double 
bonds in serum. Conjugated linoleic acids (CLAs) are a group of 
linoleic acid isomers in which the double bonds are situated in 
positions 7, 9; 8, 10; 9, 11; 10, 12; or 11, 13 with cis or trans 
configuration. The most abundant isomer in nature is rumenic 
acid (cis-9, trans-11) which is formed in the rumen by the 
anaerobic bacteria (Zlatanos et al. 2008). CLAs are mainly 
obtained from dairy products and ruminant meat, and the 
amount of CLAs in human serum is relatively low (0.05-0.33% of 
total FAs) (Ratnayake & Galli 2009). 
1.3 BIOLOGICAL FUNCTIONS OF LIPIDS 
Biological lipids can serve as structural elements of biological 
membranes and a source of energy. In addition, lipids function 
as important signaling molecules. 
1.3.1 Membranes 
Biological membranes are composed of lipids and proteins. 
Sterols and PLs form a lipid bilayer where the non-polar FA 
parts are facing each other and the polar head groups are facing 
outward (Fernández-Quintela et al. 2007). Proteins are 
embedded in the bilayer by hydrophobic interactions between 
the membrane lipids and hydrophobic domains of the proteins 
(Nelson & Cox 2000; Eyster 2007). The interactions between the 
components of the membrane are non-covalent, and thus, the 
individual lipid and protein molecules can move in the plane of 
the membrane (Nelson & Cox 2000). 
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PLs are the most abundant class of membrane lipids, and 
they are unevenly distributed in the membrane: PC is situated 
primarily in the outer layer whereas PS, 
phosphatidylethanolamine (PE), and phosphatidylinositol (PI) 
are mainly present in the inner layer of the membrane. The 
transfer of PLs from layer to another is catalyzed by scramblases 
(Eyster 2007). 
Also SM, sphingosine, and ceramide are abundant in 
membranes, and they can form hydrogen bonds with each other 
within the membrane (Eyster 2007). Cholesterol tends to fill the 
gaps among SM molecules, and the resulting membrane regions 
containing high amounts of SM and cholesterol are called lipid 
rafts (Simons & Vaz 2004; Gulati et al. 2010). The function of the 
lipid rafts is to segregate membrane components within the cell 
membrane, and they are assumed to have a role in the 
construction of signaling complexes (Bagatolli et al. 2010). 
The amounts of saturated and unsaturated FAs in the 
membrane affect the physicochemical membrane properties 
such as fluidity. SFAs rigidify the lipid bilayer and the presence 
of PUFAs increases membrane fluidity (Fernández-Quintela et 
al. 2007; Eyster 2007). Some transport systems, for example 
insulin receptor, can be altered due to changes in the membrane 
viscosity: insulin binding increases with increasing content of 
PUFAs in membrane PLs (Fernández-Quintela et al. 2007). 
1.3.2 Energy storage 
FAs are mainly stored in adipose tissue as TAGs (Lafontan & 
Langin 2009). The TAG stores in the adipose tissue are in a 
dynamic state: TAGs are continuously formed by the intake of 
FAs from the TAG-rich lipoproteins and FFAs from circulation, 
and hydrolyzed to release the FAs back to the circulation 
(Connor et al. 1996; Henry et al. 2012). Nutritional states and 
endocrine factors have an effect on the relative rate of lipid 
deposition and lipid removal (Raclot 2003). For example, fasting 
enhances fat mobilization from adipose tissue to provide FAs as 
metabolic fuel (Henry et al. 2012). 
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Oleic, palmitic, and linoleic acids are the most abundant FAs 
in adipose tissue (Hodson et al. 2008). The FA composition of 
the diet reflects to the FA composition of adipose tissue TAGs, 
but the proportion of PUFAs in adipose tissue is lower than the 
proportion of PUFAs in the diet. This can be partly explained by 
the preferential release and the low re-uptake of some highly 
polyunsaturated FAs (Raclot 2003). 
The mobilization of individual FAs from the adipose tissue 
depends on the molecular structure of the lipid and not the 
content of the particular FA in adipose tissue. In principle, SFAs 
are mobilized the least, PUFAs the most and MUFAs are 
intermediate. Especially eicosanoid precursors, arachidonic acid 
and eicosapentaenoic acid (EPA), are highly mobilized. On the 
contrary, docosahexaenoic acid (DHA), which is incorporated 
into the membrane PLs of cells and is not usually utilized for 
energy purposes or in prostaglandin synthesis, is among the 
most poorly mobilized FAs (Connor et al. 1996; Leaf 2001; 
Fernández-Quintela et al. 2007). 
1.3.3 Signaling 
Lipids have many different roles in signal transduction. For 
example, lipids are substrates of lipid kinases and lipid 
phosphatases, they act as ligands activating signal transduction 
pathways, and they function as mediators of signaling pathways. 
Furthermore, membrane lipids can serve as docking sites for 
cytoplasmic signaling proteins or give rise to cleavage products 
that act as ligands or substrates for other signaling molecules 
(Eyster 2007). Also, some proteins of signal transduction 
pathways have an affinity for lipid rafts (Cremesti et al. 2002). 
Lipid signaling pathways are interrelated and lipid mediators 
activate a significant amount of interaction among the signal 
transduction pathways (Eyster 2007). Since the lipid signaling is 
complex, this section will provide only a short introduction into 
this subject. 
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Signaling molecules cleaved by phospholipases 
Phospholipases cleave membrane PLs at different positions 
of the molecule (Figure 6) and the cleavage products participate 
in signal transduction (Eyster 2007; Richmond & Smith 2011). 
Phospholipase A1, and PLA2 specifically hydrolyze FAs from the 
sn-1 and sn-2 positions, respectively (Richmond & Smith 2011). 
The resulting lysophosphatidylcholine (LPC) is a ligand e.g. for 
specific G protein-coupled receptors that induce increase in 
intracellular Ca2+ concentration, and thus, activate protein kinase 
C (Eyster 2007). Physiologically the most important cleavage 
product of PLA2 is arachidonic acid, which is a precursor of 
inflammation mediators such as prostaglandins, leukotrienes, 
and thromboxanes (Eyster 2007; Richmond & Smith 2011). 
Platelet-activating factor (PAF), a mediator of inflammation, is 
formed when cytosolic PLA2 cleaves one FA from PC and the 
resulting LPC is acetylated (Prescott et al. 2000). 
 
 
Figure 6. Ester bond specificity of the phospholipases 
(Richmond & Smith 2011). Phospholipase A1 and A2 
(PLA1 and PLA2, respectively) are acyl hydrolases, and 
phospholipases C and D (PLC and PLD, respectively) are 
phosphodiesterases. 
 
 
 
Phospholipase C catalyzes mainly the hydrolysis of the polar 
head phosphate from phosphatidylinositol (4,5)-bisphosphate 
(Bunney & Katan 2011; Richmond & Smith 2011). The resulting 
inositol-1,4,5-trisphosphate is released into the cytoplasm and it 
acts as a calcium-mobilizing second messenger, whereas DAG 
remains bound to the membrane and activates a variety of 
effector proteins, for example protein kinase C isoforms (Eyster 
2007; Bunney & Katan 2011). Both inositol-1,4,5-trisphosphate 
and DAG participate in the regulation of several biological 
functions, e.g. fertilization (Bunney & Katan 2011). 
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Phospholipase D cleaves the polar head group mostly from 
PC to yield phosphatidic acid which activates a signaling 
cascade (Kang et al. 2011; Richmond & Smith 2011). 
Phosphatidic acid is an important second messenger that 
contributes to several cellular processes such as cell proliferation 
and cytoskeletal reorganization (Jang et al. 2012). Phosphatidic 
acid can be further degraded into lysophosphatidic acid by 
PLA2 (Eyster 2007). 
 
Signaling of sphingolipids 
Sphingolipid signaling is complex and the signaling 
molecules are interconnected (Figure 7) (Hannun & Obeid 2008). 
Sphingomyelinase can hydrolyze sphingomyelin to ceramide, 
which may be further metabolized to sphingosine by 
ceramidase (Nixon et al. 2008; Gangoiti et al. 2010). 
Furthermore, ceramide and sphingosine can be phosphorylated 
to ceramide-1-phosphate (C1P) and sphingosine-1-phosphate 
(S1P), respectively (Chalfant & Spiegel 2005; Hannun & Obeid 
2008). Sphingosylphosphorylcholine (SPC) is formed from 
sphingomyelin by sphingomyelin deacylase (Meyer zu 
Heringdorf et al. 2002; Nixon et al. 2008). 
Sphingolipids have an important role in cell signaling, and 
they can act as both first and second messengers in several 
signaling and regulatory pathways (Hannun & Obeid 2008). 
Ceramide and sphingosine mainly stimulate cell cycle arrest and 
apoptosis whereas C1P and S1P stimulate cell survival and 
proliferation and are antiapoptotic (Figure 7) (Chalfant & 
Spiegel 2005). In addition, C1P and S1P participate in 
inflammatory reactions (Chalfant & Spiegel 2005; Eyster 2007). 
C1P appears to function only as an intracellular messenger, 
whereas S1P has intracellular messenger functions and can also 
be released from the cell and bind to G protein-linked receptors 
(Eyster 2007). The biological effects of SPC are not completely 
characterized, but it has been shown to participate in 
inflammatory reactions (Nixon et al. 2008). 
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Figure 7. The interconnectivity and the effects of the bioactive sphingolipid metabolites 
(Chalfant & Spiegel 2005; Nixon et al. 2008; Fuller 2010). C1P, ceramide-1-phosphate; 
S1P, sphingosine-1-phosphate; SPC, sphingosylphosphorylcholine. A) serine 
palmitoyl-CoA transferase, B) ceramide synthase, C) ceramidase, D) sphingomyelin 
synthase, E) sphingomyelinase, F) S1P phosphatase-1, G) sphingosine kinase, H) lipid 
phosphate phosphatases, I) ceramide kinase, J) sphingomyelin deacylase, K) autotoxin, 
L) S1P lyase 
 
Lipids as ligands 
Lipids can bind to the receptors of the cell membrane, bind 
directly to the transcription factors, or indirectly affect the 
nuclear content of the transcription factors (Jump 2004; Eyster 
2007). Prostaglandins, leukotrienes, lysophospholipids, and PAF 
are examples of lipid mediators that leave the cells of origin and 
bind to G protein-coupled receptors in the membranes of the 
same or neighboring cells. Cholesterol-derived steroid 
hormones estradiol, progesterone, and testosterone travel in the 
blood to distant sites where they bind to receptors and carry out 
their biological function (Eyster 2007). 
Several nuclear receptors that belong to the steroid/thyroid 
superfamily bind FAs or their metabolites (Jump 2004). For 
example, peroxisome proliferator-activated receptor (PPAR) α 
controls the expression of genes involved in ketogenesis, 
gluconeogenesis, glycogen metabolism, and inflammation 
whereas PPAR γ regulates adipocyte differentiation (Schupp & 
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Lazar 2010). Liver X receptor family regulates the genes 
involved in the bile acid synthesis, reverse cholesterol transport, 
clearance of blood lipids, lipogenesis, and glucose uptake (Jump 
2004). 
Cholesterol and FAs have been shown to regulate the nuclear 
abundance of sterol regulatory element binding proteins 
(SREBPs) that are the transcription factors participating in the 
synthesis of cholesterol, FAs, and complex lipids. SREBP-1 
regulates FA and TAG synthesis whereas SREBP-2 is a regulator 
of cholesterol synthesis (Jump 2004). 
1.4 LIPID AND LIPOPROTEIN METABOLISM 
The metabolism of lipids includes the digestion and absorption 
of dietary lipids, as well as the synthesis and degradation of 
lipids. In addition to the lipid metabolism, also lipoprotein 
metabolism is covered. 
1.4.1 Digestion and absorption 
Fats constitute approximately 40% of the energy intake in the 
Western diet (Mu & Høy 2004). To be able to utilize the energy 
content of fats, they have to be digested and absorbed. The 
digestion of lipids begins in the mouth and stomach but occurs 
mainly in the intestine (Goodman 2010). The absorption of lipids 
can be divided into three phases; absorption of lipids into 
enterocytes, intracellular processing, and export into mesenteric 
lymph (Mansbach & Gorelick 2007). The first two of these 
phases are discussed in this section and the synthesis and 
secretion of chylomicrons is described in the Lipoprotein 
metabolism section. 
 
Digestion 
The digestion of lipids begins in the mouth by lingual lipases 
which start the digestion of TAGs. Gastric and lingual enzymes 
continue the digestion process in the stomach (Iqbal & Hussain 
2009). Dietary fat and fat-soluble vitamins form emulsions in the 
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stomach, and these lipid emulsions enter the duodenum and 
lead to the stimulation of the pancreatic enzyme secretion 
including lipases and esterases and the release of bile from the 
gallbladder (Iqbal & Hussain 2009; Goodman 2010). When the 
lipids arrive in the duodenum, only about 15% of fat has been 
digested and most of the lipids are intact (Goodman 2010). Bile 
and pancreatic juice contain bile salts, pancreatic lipase, and 
colipase which function cooperatively to ensure the efficient 
lipid digestion and absorption (Iqbal & Hussain 2009). In 
addition, colipase prevents the inactivation of lipase by the bile 
salts (Goodman 2010). 
The majority of dietary lipids in human diet are TAGs, while 
PLs and sterols are only minor components (Niot et al. 2009). 
The digestion of TAGs occurs mainly in the upper segment of 
the jejunum by pancreatic lipase (Iqbal & Hussain 2009; 
Goodman 2010), that cuts the TAG molecule from the sn-1 and 
sn-3 positions yielding 2-MAG and FFAs (Mu & Høy 2004; 
Linderborg & Kallio 2005). Pancreatic lipase can further 
hydrolyze 2-MAG to glycerol and a FFA. PLs are digested 
primarily by pancreatic PLA2 and other lipases secreted by the 
pancreas. These lipases cut FAs from the sn-2 position of PLs 
yielding FFAs and LPCs (Iqbal & Hussain 2009). Esterified 
cholesterol is hydrolyzed by cholesterol esterase, and only non-
esterified cholesterol can be incorporated into bile acid micelles 
and absorbed by enterocytes (Goodman 2010). Approximately 
50% of the cholesterol in the intestine is absorbed and the rest is 
excreted in feces (Iqbal & Hussain 2009). 
 
Absorption 
The initial step of absorption involves the transfer of digested 
lipids across the apical membrane of the enterocytes (Mansbach 
& Gorelick 2007). The products of TAG digestion, FFAs and 
2-MAG, can cross the membrane via protein-independent 
diffusion or by a protein-dependent mechanism involving fatty 
acid transport proteins (Black 2007). Diffusion based and 
protein-dependent transport mechanisms have been suggested 
also for cholesterol (Hui et al. 2008; Iqbal & Hussain 2009). 
38   
 
The absorbed products of lipid digestion must traverse the 
cytoplasm to the endoplasmic reticulum (ER) where the 
resynthesis of complex lipids takes place (Black 2007). FAs and 
MAGs are reassemblied to TAGs, and there are two pathways 
for TAG formation in the intestine (Niot et al. 2009). The 2-MAG 
pathway involves the acylation of 2-MAG with two FAs 
(Mansbach & Gorelick 2007). Prior to acylation the FAs have to 
be transformed to fatty acyl-coenzyme A-thioesters (FA-CoAs) 
(Jump & Clarke 1999). The α-glycerophosphate pathway 
involves the acylation of glycerol-3-phosphate (G-3-P) to 
phosphatidic acid, dephosphorylation of the phospholipid to 
DAG, and the acylation of the DAG to form TAG (Mansbach & 
Gorelick 2007). The 2-MAG pathway predominates in the 
intestine and it produces only TAG whereas the α-
glycerophosphate pathway can lead also to the synthesis of PLs 
(Niot et al. 2009). The absorbed and resynthesized lipids are 
then packed into chylomicron particles as discussed in the next 
section. 
1.4.2 Lipoprotein metabolism 
Lipoprotein metabolism includes the synthesis, remodeling, and 
clearance of different lipoprotein particles. This section provides 
a short introduction to these complex processes. 
Chylomicrons are formed in the enterocytes of the intestine 
by the fusion of apolipoprotein B-48 and lipid droplets. The 
lipid pool of chylomicrons consists mainly of TAGs, but there 
are also small amounts of PLs and cholesterol in the particles 
(Mansbach & Gorelick 2007). When chylomicrons enter the 
circulation, they acquire apoCs and apoE from HDL particles 
(Daniels et al. 2009; Nakajima et al. 2011). The TAGs in the 
chylomicrons are hydrolyzed by endothelial-bound lipoprotein 
lipase to yield TAG-poorer remnant particles that are 
subsequently taken up by the liver (Rader & Daugherty 2008; 
Chatterjee & Sparks 2011). The lipids of chylomicron remnants 
are then hydrolyzed to FFAs and free cholesterol that can be 
used for the synthesis of VLDL particles (Redgrave 2004). Since 
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chylomicrons exist in the circulation only in the postprandial 
state, the fasting serum does not contain chylomicrons. 
VLDLs are apoB-100 containing TAG-rich lipoproteins that 
are synthesized in the liver (Olofsson et al. 2000). The TAGs that 
are packed to the VLDLs can be derived from chylomicron and 
VLDL remnants, lipolysis of adipose tissue TAGs or de novo FA 
synthesis in the liver (Choi & Ginsberg 2011). Metabolic state 
and diet determine the relative proportions of TAGs and CEs in 
the particles, and thus, affect the size of VLDLs (German et al. 
2006). VLDL particles are secreted continuously from the liver 
and the extent of the secretion depends on the metabolic state 
(Nakajima et al. 2011). In the circulation, VLDL particles release 
FFAs to muscle and adipose tissue through the action of 
lipoprotein lipase and exchange apoCs and apoE with HDL 
particles. The loss of TAGs and apoCs and enrichment with CEs 
generates IDL particles from VLDL (Ala-Korpela 1995; Daniels 
et al. 2009). Further removal of TAGs and apoE converts IDL to 
LDL (Vergès 2009a). In principle, the heterogenous sizes of LDL 
particles are mainly caused by the metabolic differences in the 
formation of these particles (German et al. 2006). About half of 
the VLDL remnants are taken up by the liver and the rest are 
transformed to LDL (Lusis & Pajukanta 2008). Also IDL and 
LDL remnants are subsequently cleared by the liver (Lusis et al. 
2004). 
HDL synthesis begins with the formation of nascent HDLs 
that contain two or more apolipoprotein molecules (only apoA-I 
or both apoA-I and apoA-II), PLs, and free cholesterol (Rye et al. 
2009). Nascent particles are secreted from the liver or they can 
also be assembled in the serum from the individual components 
(Lusis & Pajukanta 2008; Rye et al. 2009). Lecithin-cholesterol 
acyl transferase (LCAT) converts free cholesterol molecules of 
nascent HDLs to CEs that partition into the center of the 
particles and more free cholesterol can be added to the particles 
(Daniels et al. 2009). This increases the particle size and 
transforms the nascent HDLs into the mature spherical HDLs 
(Ordovas 2003; Brufau et al. 2011). HDL particles are constantly 
remodeled in the circulation and they also interact with other 
40   
 
lipoproteins (Rye et al. 2009). Cholesteryl ester transfer protein 
exchanges CEs of HDL for TAGs of LDL and VLDL and 
remodels HDL into smaller particles (Daniels et al. 2009; Rye et 
al. 2009). Phospholipid transfer protein transfers mainly PLs 
from VLDL into HDL, as well as between individual HDL 
particles that results in either smaller or larger particles. 
Furthermore, endothelial lipase hydrolyzes PLs and hepatic 
lipase hydrolyzes TAGs and PLs of HDLs to yield smaller HDL 
particles (Rye et al. 2009). Apolipoprotein and PL composition 
of HDL affects the metabolic outcome of the lipoprotein and the 
HDL subclass distribution in serum is due to different clearance 
rates of these particles by the liver (German et al. 2006). 
1.4.3 Biosynthesis of lipids 
Since lipids have several roles, their biosynthesis is crucial for 
normal cellular function. This section describes the synthesis of 
FAs, glycerolipids, cholesterol, and sphingolipids. 
 
Synthesis of fatty acids 
The de novo synthesis of FAs from acetyl-CoA and malonyl-
CoA is a cyclic process including a repeating four-step sequence 
(Figure 8). Each passage through the cycle extends the FA chain 
by two carbons. The reactions of the FA synthesis are catalyzed 
by a multi-enzyme complex called fatty acid synthase (FAS). 
After seven cycles, the final product is palmitic acid (Smith 1994; 
Nelson & Cox 2000). 
The FA biosynthesis occurs in cytosol and begins with the 
conversion of acetyl-CoA into malonyl-CoA by acetyl-CoA 
carboxylase, which is the rate-limiting step in the synthesis 
process (Nelson & Cox 2000; Chan & Vogel 2010). Then, one 
acetyl-CoA and one malonyl-CoA are transferred to specific 
thiol sites of the FAS complex. The acetyl group binds to the β-
ketoacyl-ACP synthase and the malonyl attaches to the acyl 
carrier protein (ACP) domain (Figure 8) (Smith 1994; Nelson & 
Cox 2000). 
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Figure 8. Reactions of the fatty acid biosynthesis (Smith 1994; Nelson & Cox 2000; 
Chan & Vogel 2010). Acetyl and malonyl groups are transferred to the β-ketoacyl-
ACP synthase and acyl carrier protein (ACP) domains of the fatty acid synthase (FAS) 
complex, respectively. The four-step cycle involves the condensation of the malonyl and 
acyl groups (1), reduction of the β-keto group (2), dehydration (3), and reduction of the 
double bond (4). To initiate another cycle, the acyl group is transferred from the ACP 
domain to the β-ketoacyl-ACP synthase and a new malonyl group is attached to the 
ACP domain. CoA, coenzyme A 
 
The first reaction in the four-step cycle is the condensation of 
the activated acetyl and malonyl groups by β-ketoacyl-ACP 
synthase to form acetoacetyl-ACP. Secondly, the 
acetoacetyl-ACP is reduced by β-ketoacyl-ACP reductase to 
yield D-β-hydroxybutyryl-ACP (Smith 1994; Nelson & Cox 2000). 
The third step involves the removal of water and the formation 
of a double bond to the molecule by β-hydroxyacyl-ACP 
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dehydratase. Finally, the double bond is reduced to form 
butyryl-ACP by the action of enoyl-ACP reductase. The butyryl 
group is then transferred from the phosphopantetheine SH 
group of ACP to the cysteine SH group of β-ketoacyl-ACP 
synthase. To start the next cycle, another malonyl group is 
attached to the phosphopantetheine SH group of ACP (Nelson 
& Cox 2000; Chan & Vogel 2010). 
Synthesized or diet derived FAs can be further desaturated 
and/or elongated into long and very-long-chain FAs by specific 
membrane-bound enzymes in the ER (Figure 9) (Jakobsson et al. 
2006; Guillou et al. 2010). The elongation involves the addition 
of two-carbon units (malonyl-CoA) to a FA-CoA (Wallis et al. 
2002). Enzymatic steps involved in the elongation process are 
the same as for the synthesis of palmitic acid (Jakobsson et al. 
2006). However, different enzyme systems are involved and 
CoA functions as the acyl carrier instead of ACP (Nelson & Cox 
2000). 
Desaturases add double bonds to specific positions of the FA 
chains. Mammals express Δ9-, Δ6-, and Δ5-desaturase activities. 
The number after delta indicates the position at which the 
double bond is introduced counting from the carboxylic end of 
the FA (Guillou et al. 2010). For example, Δ9-desaturase 
synthesizes palmitoleic and oleic acids from palmitic and stearic 
acids, respectively (Kawashima et al. 2009). However, mammals 
lack Δ12- and Δ15-desaturases, and thus, they cannot synthesize 
linoleic (18:2 ω-6) and α-linolenic acids (18:3 ω-3) and they have 
to be obtained from diet (Wallis et al. 2002; Poudyal et al. 2011). 
These two essential FAs serve as precursors for the synthesis of 
longer ω-6 and ω-3 PUFAs (Figure 9) (Hornstra et al. 1995; Smit 
et al. 2004; Das 2008). Since the ω-3 and ω-6 FAs compete for the 
same desaturases and elongases, the intake of these FAs 
determines the status of serum ω-3 and ω-6 FAs (Assies et al. 
2010). For example, a high intake of linoleic acid promotes the 
endogenous synthesis of arachidonic acid (20:4 ω-6) and reduces 
the synthesis of ω-3 FAs deriving from α-linolenic acid 
(Warensjö et al. 2006). It has been proposed that an ω-6/ω-3 ratio 
of <4:1 in serum represents a healthy balance (Assies et al. 2010). 
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Figure 9. Pathways of fatty acid chain elongation and desaturation (Wallis et al. 2002; 
Warensjö et al. 2006; Assies et al. 2010). Since mammals lack Δ12 and Δ15 
desaturases, they have to obtain linoleic (18:2 ω-6) and α-linolenic acids (18:3 ω-3) 
from their diet. 
 
Synthesis of glycerolipids 
The de novo synthesis of TAGs and glycerophospholipids are 
discussed together since their synthesis pathways share several 
reactions (Figure 10). More than 90% of TAGs are synthesized 
via the G-3-P pathway under normal physiological conditions in 
the liver (Coleman & Lee 2004). In the intestine, the major route 
for TAGs is the 2-MAG pathway, as discussed earlier. 
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Figure 10. Synthesis pathways of triacylglycerides (TAGs) and glycerophospholipids. 
Glycerophospholipids are synthesized through the de novo pathway (Kennedy pathway) 
and modified through the remodeling pathway (Lands’ cycle) (Coleman & Lee 2004; 
Yen et al. 2008; Shindou & Shimizu 2009). TAGs are synthesized mainly via the 
glycerol-3-phosphate (G-3-P) pathway, which is a part of the Kennedy pathway. Some 
lysophosphatidic acid (LPA) is metabolized from dihydroxyacetone phosphate (DHAP). 
CDP-DAG, cytidine diphospho-diacylglyceride; CL, cardiolipin; LPC, 
lysophosphatidylcholine; LPE, lysophosphatidylethanolamine; LPG, 
lysophosphatidylglycerol; LPI, lysophosphatidylinositol; LPS, lysophosphatidylserine; 
PC, phosphatidylcholine; PE, phosphatidylethanolamine; PG, phosphatidylglycerol; PI, 
phosphatidylinositol; PLA2, phospholipase A-2; PS, phosphatidylserine 
 
Glycerophospholipids are synthesized by the de novo 
pathway (Kennedy pathway) and modified by the remodeling 
pathway (Lands’ cycle) (Figure 10) (Shindou & Shimizu 2009). 
The first step in the Kennedy pathway (and also in the G-3-P 
pathway) involves the formation of lysophosphatidic acid from 
G-3-P (Coleman & Lee 2004). Lysophosphatidic acid is then 
metabolized into phosphatidic acid, which is subsequently 
converted either into DAG or cytidine diphospho-DAG 
(CDP-DAG). DAG can be transformed into TAG, PC or PE 
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whereas PS is synthesized from PC or PE (Coleman & Lee 2004). 
CDP-DAG can be converted to PI, PS or phosphatidylglycerol. 
After synthesis of glycerophospholipids, their FA composition 
at the sn-2 position is altered through the Land’s cycle by actions 
of PLA2s and lysophospholipid acyltransferases (Shindou & 
Shimizu 2009). 
 
Synthesis of cholesterol 
Cholesterol synthesis is a multi-step process including almost 
30 enzymes, and the main reactions are shown in Figure 11 
(Gulati et al. 2010). Briefly, acetoacetyl-CoA is formed from two 
acetyl-CoA molecules, after which acetoacetyl-CoA condenses 
with acetyl-CoA forming β-hydroxy-β-methylglutaryl-CoA 
(HMG-CoA) (Panda et al. 2011). HMG-CoA is then reduced to 
mevalonate by HMG-CoA reductase which is the rate-limiting 
step of the cholesterol synthesis (Gulati et al. 2010). 
Furthermore, mevalonate is converted to activated isoprene 
units through phosphorylation and decarboxylation reactions 
(Panda et al. 2011). Polymerization of isoprene units produces 
squalene, which undergoes cyclization to yield lanosterol 
(Nelson & Cox 2000; Gulati et al. 2010). Finally, 19 reactions are 
required to convert lanosterol to cholesterol (Gulati et al. 2010). 
CEs can be synthesized from cholesterol and acyl-CoA by 
intracellular enzyme acyl-CoA-cholesterol acyl transferase 
(ACAT) that has specificity for oleic acid (Hodson et al. 2008; 
Gulati et al. 2010). CE formation may also occur in serum where 
LCAT transfers a FA from sn-2 position of PC to cholesterol 
(Nelson & Cox 2000; Hodson et al. 2008). The specificity of 
LCAT depends on the FA, and the order is linoleic acid > oleic 
acid > arachidonic acid > SFA which explains the high 
proportion of linoleic acid in CEs. Since serum contains more 
linoleic acid CE than oleic acid CE, most of the serum CEs must 
be derived from the LCAT pathway (Hodson et al. 2008). 
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Figure 11. Main reactions of the cholesterol synthesis with key enzymes (A–F) 
(Nelson & Cox 2000; Gulati et al. 2010; Panda et al. 2011). A) Acetoacetyl-CoA 
thiolase, B) β-hydroxy-β-methylglutaryl-CoA (HMG-CoA) synthase, C) HMG-CoA 
reductase, D) mevalonate kinase, phosphomevalonate kinase, mevalonate-5-
pyrophosphate decarboxylase, E) geranyl pyrophosphate synthase, farnesyl 
pyrophosphate synthase, squalene synthase, F) squalene epoxidase, squalene epoxide 
cyclase. Conversion of lanosterol to cholesterol requires 19 reactions but they are not 
specified here. CoA, coenzyme A 
 
Synthesis of sphingolipids 
The synthesis of ceramide begins at the cytosolic surface of 
the ER (Fuller 2010). The first and rate-limiting step of the 
sphingolipid synthesis involves a condensation of serine and 
palmitoyl-CoA to form 3-ketosphinganine (Figure 12). Then, 
3-ketosphinganine is reduced to dihydrosphingosine which is 
acylated to yield dihydroceramide (Hannun & Obeid 2008; 
Gulati et al. 2010). Desaturation of dihydroceramide produces 
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ceramide that serves as a precursor for complex sphingolipids at 
the trans-Golgi (Gulati et al. 2010). 
Sphingomyelin is formed when phosphocholine group of PC 
is transferred to the 1-hydroxyl group of ceramide. 
Glycosphingolipid synthesis begins with glucosylation of 
ceramide by glucosylceramide synthase to yield 
glucosylceramide which is then converted to lactosylceramide 
by the action of galactosyltransferase I. Lactosylceramide serves 
as a substrate for the synthesis of gangliosides (Fuller 2010). 
 
 
 
Figure 12. The reactions of sphingolipid synthesis with key enzymes (A–D) (Gulati et 
al. 2010). A) serine palmitoyltransferase, B) ketosphinganine reductase, 
C) dihydroceramide synthase, D) dihydroceramide desaturase. Ceramide is a precursor 
of complex sphingolipids. 
1.4.4 Degradation of lipids 
Oxidation rates of amino acids and carbohydrates are primarily 
determined by intakes of protein and carbohydrate, but the rate 
of fat oxidation is set mainly by the gap between the total energy 
expenditure and energy intake in the form of protein and 
carbohydrates (Fernández-Quintela et al. 2007). FA oxidation is 
an important metabolic pathway for energy homeostasis in the 
liver, heart, and skeletal muscles especially during fasting. Most 
of the tissues, excluding the brain, are able to use FAs directly to 
generate energy (Houten & Wanders 2010). In addition, the liver 
converts FAs into ketone bodies which can be used for energy 
production in all tissues including the brain (Rinaldo et al. 2002; 
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Houten & Wanders 2010). This section describes the catabolism 
of FAs, acylglycerides, PLs, cholesterol, and sphingolipids. 
 
Catabolism of fatty acids 
There are three mechanisms for the degradation of FAs 
including α-, β-, and ω-oxidation, of which β-oxidation is the 
principal pathway for the oxidation of serum FFAs or 
lipoprotein associated TAGs (Wanders et al. 2003; Wanders et al. 
2011). Prior to β-oxidation, the TAGs must be first hydrolyzed 
by the endothelium-bound lipoprotein lipase (Houten & 
Wanders 2010). 
There are mitochondrial and peroxisomal β-oxidation 
systems which are functionally complementary but have 
different roles (Reddy & Hashimoto 2001). Short- (<C8) and 
medium-chain (C8–C12) FAs are exclusively and long-chain (C14–
C20) FAs are predominantly β-oxidized in mitochondria (Reddy 
& Hashimoto 2001; Wanders & Waterham 2006). There are some 
FAs that cannot be β-oxidized in mitochondria including e.g. 
very long-chain FAs (>C20), pristanic acid (2,6,10,14-
tetramethylpentadecanoic acid), long-chain dicarboxylic acids, 
certain PUFAs such as tetracosahexaenoic acid (24:6), some 
prostaglandins and leukotrienes, and vitamins E and K, which 
are β-oxidized in peroxisomes (Wanders & Waterham 2006). 
However, peroxisomes are not able to β-oxidize FAs completely 
and the FAs are only chain-shortened to shorter chain FAs 
which are then transferred to mitochondria for full oxidation 
(Wanders et al. 2011). Only saturated unbranched FAs and 2-
methyl-branched FAs can undergo direct β-oxidation in 
peroxisomes, other FAs need to be remodeled prior to the β-
oxidation (Wanders & Waterham 2006). 
The mitochondrial β-oxidation involves series of four enzyme 
reactions which sequentially remove an acetyl-CoA molecule 
per cycle from the carboxy-terminal of the initial FA substrate 
(Figure 13) (Houten & Wanders 2010). Each step of the cycle is 
catalyzed by multiple chain-length specific enzymes (Wanders 
et al. 2011). In addition to the acyl-CoA and an acetyl-CoA, the 
β-oxidation cycle yields also one nicotinamide adenine 
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dinucleotide and one flavin adenine dinucleotide as electron 
carriers (Houten & Wanders 2010). The acyl-CoA proceeds to 
another cycle of FA oxidation, and the acetyl-CoA can enter the 
citric acid cycle for further oxidation or condense to ketone 
bodies (Reddy & Hashimoto 2001). The electron carriers deliver 
electrons to the electron transport chain (Houten & Wanders 
2010). The reactions of the β-oxidation cycle in peroxisomes are 
analogous but the reactions are catalyzed by different enzymes 
compared with the mitochondrial system (Mukherji et al. 2003; 
Wanders et al. 2011). Human peroxisomes have two β-oxidation 
systems of which one is an inducible pathway metabolizing 
long-chain FAs and the other is a constitutive pathway 
oxidizing pristanic and bile acids having (2S)-stereochemistry 
(Mukherji et al. 2003). 
 
 
 
Figure 13. Mitochondrial fatty acid β-oxidation (Houten & Wanders 2010). The first 
step of the cycle involves the dehydrogenation of the acyl-CoA by acyl-CoA 
dehydrogenase (A) producing trans-2-enoyl-CoA. Then the formed double bond is 
hydrated by enoyl-CoA hydratase (B), and 3-hydroxyacyl-CoA dehydrogenase (C) 
dehydrogenates the resulting L-3-hydroxyacyl-CoA to yield 3-ketoacyl-CoA. In the 
final step, the thiolytic cleavage of the 3-ketoacyl-CoA catalyzed by 3-ketoacyl-CoA 
thiolase (D) forms an acyl-CoA shortened by two carbons and an acetyl-CoA. The 
peroxisomal β-oxidation cycle is analogous but the reactions are catalyzed by different 
enzymes compared with the mitochondrial system. CoA, coenzyme A; FADH2, flavin 
adenine dinucleotide; NADH, nicotinamide adenine dinucleotide 
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FAs having a methyl group or any other functional group 
attached to the carbon-3 cannot be degraded by β-oxidation, and 
they must first undergo α- or ω-oxidation (Wanders et al. 2003; 
Wanders et al. 2011). The α-oxidation of FAs is confined to 
peroxisomes and accepts only acyl-CoA esters as substrate. In 
the oxidation process, the FA is shortened by one carbon atom, 
and the functional group is then at carbon-2 (Wanders & 
Waterham 2006). For example, the α-oxidation of phytanoyl-
CoA is illustrated in Figure 14. 
 
 
 
Figure 14. Degradation of phytanoyl-CoA by α-oxidation (Mukherji et al. 2003). 
Phytanoyl-CoA is converted to 2-hydroxyphytanoyl-CoA by phytanoyl-CoA 
2-hydroxylase (A). The resulting 2-hydroxyphytanoyl-CoA is converted into pristanal 
and formyl-CoA by phytanoyl-CoA lyase (B). Pristanoyl-CoA is formed in reactions 
catalyzed by pristanal dehydrogenase (C) and very-long-chain fatty acyl-CoA 
synthetase (D). Pristanoyl-CoA then undergoes three cycles of β-oxidation in the 
peroxisome and the resulting chain shortened FA-CoA is then transferred to 
mitochondrion for further oxidation (Wanders et al. 2011). CoA, coenzyme A 
 
FA ω-oxidation takes place almost exclusively in the smooth 
ER by cytochrome P450 4 (CYP4) family, and they 
ω-hydroxylate saturated, branched, and unsaturated FAs, as 
well as eicosanoids. Members of CYP4B, CYP4A, and CYP4F 
subfamilies metabolize FAs with chain lengths C7–C9, C10–C16, 
and C18–C26, respectively (Hardwick et al. 2009). The ω-oxidation 
involves ω-hydroxylation of the ω-carbon of a FA, and the 
sequential action of cytosolic alcohol and aldehyde 
dehydrogenases yield corresponding dicarboxylic acids (Nelson 
& Cox 2000; Hardwick et al. 2009). 
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Catabolism of acylglycerides 
There are several lipases that degrade dietary or endogenous 
TAGs in different organs. Human gastric lipase and human 
pancreatic lipase catalyze the hydrolysis of dietary TAGs into 
DAGs and subsequently into MAGs in the stomach and 
intestine, respectively. Hepatic lipase is involved in the 
degradation of TAGs from HDL particles. Lipoprotein lipase 
hydrolyzes TAGs from the sn-1 and sn-3 positions of TAGs of 
chylomicrons and VLDLs, and is expressed in adipose tissue 
and muscles. TAG hydrolase degrades TAGs yielding DAGs 
and MAGs especially in the liver (Karantonis et al. 2009). 
Adipose triacylglyceride lipase, hormone-sensitive lipase 
(HSL), and monoacylglycerol lipase degrade acylglycerides in 
the adipose tissue (Karantonis et al. 2009; Zechner et al. 2009). 
Adipose triacylglyceride lipase can hydrolyze both TAGs and 
DAGs but it exhibits 10-fold higher substrate specificity for 
TAGs. HSL is able to hydrolyze several lipids such as TAGs, 
DAGs, MAGs, and CEs, of which DAG is the preferable 
substrate. HSL slightly prefers unsaturated medium-chain FAs 
over saturated long-chain FAs in TAG substrates and it 
preferentially hydrolyzes FAs from sn-1 and sn-3 positions. 
Monoacylglycerol lipase specifically degrades MAGs and has no 
activity against DAGs or TAGs (Zechner et al. 2009). 
 
Catabolism of phospholipids 
PLs are degraded by the action of PLA2 superfamily enzymes 
which catalyze the hydrolysis of the ester bond at the sn-2 
position of a phospholipid yielding a FFA and a 
lysophospholipid. The superfamily consists of secreted, 
cytosolic, Ca2+ independent, and lysosomal PLA2s, as well as 
PAF acetylhydrolases (Burke & Dennis 2009). The degradation 
products represent the first step in generating second 
messengers that have various physiological roles, as discussed 
earlier. 
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Catabolism of cholesterol 
Bile acid biosynthesis is the main catabolic and non-
reversible departure point of cholesterol. About 50% of the de 
novo synthesized cholesterol is converted to bile acids in human 
liver (Gulati et al. 2010). Primary bile acids (cholic acid and 
chenodeoxycholic acid) can be synthesized from cholesterol via 
the classic (neutral) pathway, which accounts for approximately 
75% of the liver bile acid synthesis, or via the alternative (acidic) 
pathway (Li & Chiang 2009; Gulati et al. 2010). Secondary bile 
acids are formed from primary bile acids in the intestine by the 
action of bacterial enzymes (Li & Chiang 2009). 
 
Catabolism of sphingolipids 
The breakdown of complex sphingolipids occurs mainly in 
the lysosomes but the non-glycosylated sphingolipids such as 
ceramide and sphingomyelin can also be degraded in other sub-
cellular locations (Fuller 2010; Kolter & Sandhoff 2010). 
Catabolism of sphingolipids prevents their accumulation and 
also generates and recycles intermediates and metabolites such 
as ceramide and sphingosine (Gulati et al. 2010). 
Prior to the lysosomal degradation of sphingolipids, these 
lipids need to be transported to the lysosomes, and it occurs 
mainly by endocytosis, phagocytosis or autophagy (Kolter & 
Sandhoff 2006). Sphingomyelin is degraded to form ceramide 
and phosphocholine by sphingomyelinases (Gulati et al. 2010; 
Fuller 2010). The saccharide molecules of glycosphingolipids are 
sequentially removed from the non-reducing end of the 
oligosaccharide part by exohydrolases (Kolter & Sandhoff 2006; 
Fuller 2010). Glycosphingolipids having less than four sugar 
residues require the presence of sphingolipid activator proteins 
to be degraded. Sphingolipid activator proteins mediate the 
interaction between the membrane-bound lipid substrate and 
the water-soluble enzyme or activate the enzyme directly 
(Kolter & Sandhoff 2006). The degradation of gangliosides 
involves several steps in which the saccharide residues are 
removed and the final product is ceramide (Fuller 2010). 
Ceramide can be further degraded to sphingosine and a FA by 
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ceramidases (Hannun & Obeid 2008). The degradation of 
sphingolipids yields monosaccharides, sialic acid, FAs, 
ceramide, and sphingosine, which can leave the lysosome 
through the transporters of the membrane (Kolter & Sandhoff 
2006). 
1.5 LIPID PEROXIDATION 
Oxidative stress is a condition in which the levels of oxidizing 
components and the relevant neutralizing substances are 
imbalanced leading to a potential damage to cells and organs 
(Opara 2006; Basu 2010). Especially the double bonds of PUFAs 
are susceptible to oxidation (Leopold & Loscalzo 2009). The 
interest for studying the oxidative stress is mainly due to its role 
in the development of chronic degenerative diseases such as 
coronary heart disease, cancer, and the degenerative processes 
associated with aging (Fernandez-Panchon et al. 2008). 
1.5.1 Mechanisms of lipid peroxidation 
There are three different lipid peroxidation mechanisms; free 
radical-mediated, free radical-independent, and enzymatic 
oxidation (Niki et al. 2005; Niki 2009). All the mechanisms result 
in specific products and different antioxidants inhibit each type 
of peroxidation mechanism (Niki 2009). PUFAs and cholesterol 
are oxidized both by the enzymatic and non-enzymatic 
pathways (Niki et al. 2005). 
 
Free radical-mediated peroxidation of polyunsaturated fatty acids 
Free radical is a molecule that has unpaired electrons in its 
atomic structure. This structure makes free radicals relatively 
unstable and very reactive, and they can oxidize proteins, DNA, 
and lipids (Opara 2006). Free radical-mediated lipid 
peroxidation proceeds by a chain mechanism meaning that one 
initiating free radical can oxidize several lipid molecules (Figure 
15) (Niki 2009). There are five elementary reactions: (1) 
abstraction of a bisallylic hydrogen of PUFA by a chain 
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initiating radical or chain carrying peroxyl radicals to yield a 
pentadienyl carbon-centered radical (initiation reaction), (2) 
reaction of the lipid radical with molecular oxygen resulting in a 
lipid peroxyl radical (propagation reaction), (3) fragmentation of 
the lipid peroxyl radical to give oxygen and a lipid radical, 
which is a reverse of reaction (2), (4) rearrangement of the 
peroxyl radical to a more stable radical, and (5) cyclization of the 
peroxyl radical (Niki 2009; Yin et al. 2011). The cyclization 
reaction (5) takes place only during the oxidation of PUFAs 
having more than three double bonds (Niki et al. 2005). The 
oxidation process is terminated when two primary or secondary 
peroxyl radicals react together forming non-radical products 
(Yin & Porter 2005; Yin et al. 2011). 
 
 
 
Figure 15. Reactions of the lipid peroxidation (Galleano et al. 2010). LH, lipid 
molecule; L., lipid radical; LOO., lipid peroxyl radical; LOOH, lipid hydroperoxide 
 
Non-radical, non-enzymatic peroxidation of polyunsaturated fatty 
acids 
Ozone and singlet oxygen oxidize lipids by non-radical 
mechanisms. Singlet oxygen oxidizes unsaturated lipids mainly 
by ene-reaction to yield hydroperoxide with simultaneous 
double bond migration. Minor side reactions include 1,4-
addition to give 1,4-endoperoxide and 1,2-addition to yield 
dioxetane, which readily decomposes to result in 
chemiluminescent carbonyl compounds (Niki 2009). Oxidation 
induced by ozone results in ozonides and cleavage products 
(Uppu et al. 1995). 
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Enzymatic peroxidation of polyunsaturated fatty acids 
There are enzymes such as lipoxygenase and cyclooxygenase 
that oxidize mainly arachidonic acid regio-, stereo-, and 
enantiospecifically (Schneider et al. 2007). Lipoxygenase 
enzymes produce hydroxyeicosatetraenoic acids which are then 
metabolized to leukotrienes. Cyclooxygenase enzymes oxidize 
arachidonic acid to prostaglandins, prostacyclin, and 
thromboxane. In addition, CYP enzymes metabolize arachidonic 
acid to dihydroxyeicosatetraenoic acids, as well as 
epoxyeicosatrienoic acids (Roman 2002). 
 
Oxidation of cholesterol 
Also cholesterol can be oxidized by all the three mechanisms 
described above, and the oxidation products are called 
oxysterols (Niki 2009). Major oxidation products from different 
cholesterol oxidation pathways are shown in Figure 16. 
 
 
 
Figure 16. Main oxysterols from free radical mediated, non-radical and non-enzymatic, 
as well as from enzymatic oxidation (Niki 2009). 
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1.5.2 Defense mechanisms against oxidation 
Organisms have various antioxidant defense mechanisms 
against oxidation including small antioxidant molecules and 
antioxidative enzymes. The actions of these different 
antioxidants are shortly discussed in this section. 
 
Small antioxidant molecules 
The group of small antioxidant molecules consists of several 
different components such as certain vitamins, trace elements, 
glutathione, uric acid, and polyphenols, and these compounds 
have a variety of antioxidant mechanisms. For example, 
vitamins (e.g. vitamin C and vitamin E) can act as donors and 
acceptors of reactive oxygen species, and trace elements such as 
selenium and zinc, act as cofactors regulating the activities of 
antioxidant enzymes (Opara 2006). Glutathione can scavenge 
free radicals and act as a reducing cofactor of glutathione 
peroxidase (Galleano et al. 2010). Uric acid is the end-product of 
enzymatic purine catabolism, and it functions both as a primary 
radical scavenger and an inhibitor of the iron-catalyzed 
oxidation of ascorbate (Nyyssönen et al. 1997). 
Polyphenols are polyhydroxylated phytochemicals which are 
present mainly in plants (Lotito & Frei 2006). There are two 
subgroups of polyphenols including flavonoids and non-
flavonoid compounds (Fraga et al. 2010). Flavonoids can be 
divided into several subclasses according to their structure; 
flavones, isoflavones, flavanones, flavonols, anthocyanidins, and 
flavanols (Table 5) (Mladenka et al. 2010). Stilbenes, phenolic 
acids, and lignans are non-flavonoid polyphenols, and examples 
of their structures are shown in Figure 17 (Fraga et al. 2010). 
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Table 5. Chemical structures of flavonoid subclasses (Manach et al. 2004; Lotito & 
Frei 2006; Galleano et al. 2010). 
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Figure 17. Examples of the structures of non-flavonoid polyphenols (Manach et al. 
2004). 
 
Several antioxidant mechanisms have been proposed for the 
compounds having a polyphenol structure (Fraga et al. 2010). In 
vitro studies suggest that polyphenols have a free radical 
scavenging activity and an ability to bind transition metal ions 
(Mladenka et al. 2010). However, the poor absorption and 
extensive metabolism of polyphenols does not allow high serum 
concentrations of polyphenols, and thus, limit the capacity of 
these compounds to act as direct antioxidants (Lotito & Frei 
2006). Free radical scavenging function of polyphenols is 
relevant only in tissues that are directly exposed to flavonoids 
such as the gastrointestinal tract (Galleano et al. 2010). Indirect 
antioxidant mechanisms of polyphenols include interactions 
with membrane components and inhibition of free radical 
forming enzymes e.g. xanthine oxidase and lipoxygenases 
(Mladenka et al. 2010; Galleano et al. 2010). 
 
Antioxidant enzymes 
Glutathione peroxidase, catalase, and cytosolic superoxide 
dismutase are examples of antioxidant enzymes. Glutathione 
peroxidase catalyzes the reduction of hydroperoxides by using 
thiol cofactors (Bhabak & Mugesh 2010). Catalase decomposes 
hydrogen peroxide resulting in water and oxygen (O2) (Nelson 
& Cox 2000; Khan et al. 2010). Superoxide dismutase can 
catalyze the dismutation of superoxide radical (.O2-) to hydrogen 
peroxide and oxygen (Khan et al. 2010; Torsdottir et al. 2010). 
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1.6 ALTERATIONS IN LIPID METABOLISM 
FA composition is widely used as an indicator of disease risk 
since many disease states involve alterations in FA profiles. In 
this section, lipid alterations in some common metabolic states 
and diseases, such as obesity, diabetes, atherosclerosis, 
metabolic syndrome, and Alzheimer’s disease (AD) are shortly 
discussed. 
1.6.1 Obesity 
Obesity is a state in which the storage capacity of adipose tissue 
is exceeded, and TAGs accumulate also in the liver and muscles 
(Langeveld & Aerts 2009). Body mass index (BMI) is used as a 
measurement of body fat, and it is calculated as weight (kg) 
divided by height squared (m2) (Ahima 2011). Overweight is 
defined as a BMI ≥ 25 kg/m2 and obesity as a BMI ≥ 30 kg/m2 
(Flegal et al. 2010; Ahima 2011). Environmental and lifestyle 
factors have a strong impact on the development of obesity but 
also genetic variation may determine the susceptibility of body 
fat accumulation and lipid disturbances (Pietiläinen et al. 2007). 
Obesity increases the risk for decreased insulin sensitivity which 
is characterized by reduced insulin-mediated glucose uptake 
and impaired suppression of lipolysis and hepatic glucose 
production (Langeveld & Aerts 2009). Furthermore, obesity is a 
risk factor for several diseases such as coronary heart disease, 
type 2 diabetes, stroke, and certain types of cancer (Holland & 
Summers 2008; Ahima 2011). 
Obese individuals tend to have increased concentrations of 
serum TAGs, large VLDL particles, small dense LDL particles, 
and low amounts of HDL cholesterol compared to non-obese 
individuals (Pietiläinen et al. 2007). In addition, obesity involves 
decreased concentrations of ether PLs that have antioxidant 
activities, as well as increased amounts of LPCs that have 
proinflammatory and proatherogenic properties. These lipid 
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changes are associated with insulin resistance (Pietiläinen et al. 
2007; Kontush & Chapman 2010). 
Also sphingolipid metabolism is altered in obesity. Increased 
saturated FAs within circulating lipoprotein particles contribute 
to increased ceramide synthesis in peripheral tissues. 
Additionally, chronic low-level inflammation, which is 
associated with obesity, contributes to the induction of ceramide 
accumulation (Holland & Summers 2008). Excessive 
sphingolipids complicate insulin signaling and promote 
inflammation (Langeveld & Aerts 2009). 
1.6.2 Diabetes 
Diabetes is a complex metabolic disorder involving defects in 
glucose and insulin homeostasis. Type 1 diabetes is linked 
mostly to genetics and the production of autoantibodies that 
destroy pancreatic β-cells, and thus, the body stops making or 
makes only a tiny amount of insulin. Type 2 diabetes is caused 
mainly by insulin resistance and is related to obesity and age 
(Rains & Jain 2011). Type 2 diabetes is more common, and it 
accounts for 90–95% of diabetes diagnoses (Wright et al. 2006). 
 
Lipid abnormalities in type 1 diabetes 
Quantitative lipid abnormalities in untreated type 1 diabetes 
include decreased LDL and HDL cholesterol levels and 
increased amounts of TAG-rich lipoproteins (chylomicrons and 
VLDLs) that lead to hypertriglyceridaemia (Vergès 2009a). 
Patients with well-controlled blood glucose tend to have similar 
levels of serum lipids and lipoproteins as healthy controls 
(Sorensen et al. 2010). When considering the levels of individual 
lipid species, some sphingomyelin and ether 
phosphatidylcholine species have been suggested to decrease in 
type 1 diabetic individuals compared with controls (Orešic et al. 
2008; Sorensen et al. 2010). 
There are also qualitative lipid abnormalities that are 
common in type 1 diabetic patients both with poor and good 
glycaemic control (Vergès 2009a). VLDL particles are often 
enriched with CEs at the expense of TAGs, and the number of 
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small, dense LDL particles is increased (Skyrme-Jones et al. 
2000; Vergès 2009a). Furthermore, the oxidation of LDL may be 
increased and HDL particles are commonly enriched with TAGs 
(de Castro et al. 2005; Vergès 2009a). 
A part of patients with long-standing type 1 diabetes suffer 
from diabetic nephropathy (a leading cause of chronic kidney 
disease) involving increased urinary albumin excretion (Gross et 
al. 2005). Our study revealed that diabetic kidney disease 
consists of diverse phenotypes (Mäkinen et al. 2012a). According 
to the study, IDL and LDL lipids together with PLs and 
unsaturated FAs are increased in the early phase of the disease, 
but not in the late phase. Simultaneously, the patients express 
extensive metabolic diversity regarding SFAs, inflammation, 
and HDL metabolism, and this diversity may be one 
explanation to the variability in kidney disease onset (Mäkinen 
et al. 2012a). In the final phase, the sphingolipid pathway could 
be a mediator of lipotoxicity from SFAs on the path to end-stage 
renal disease and/or premature death (Mäkinen et al. 2012a; 
Mäkinen et al. 2012b). 
 
Lipid abnormalities in type 2 diabetes 
Type 2 diabetic patients have typically normal LDL 
cholesterol levels but HDL levels are decreased due to increased 
catabolism of these particles (Taskinen 2003; Adiels et al. 2008; 
Vergès 2009b; Betteridge 2011). In addition, overproduction of 
large VLDL particles, as well as accumulation of cholesterol-
enriched remnant lipoprotein particles are common 
abnormalities (Taskinen 2003; Adiels et al. 2008; Betteridge 
2011). Several atherogenic modifications including small, dense 
and TAG-rich LDL, oxidized LDL, and glycated LDL are typical 
in LDL particles of type 2 diabetic subjects. Also HDL particles 
are enriched with TAGs, or they can be glycated. Furthermore, 
the antioxidative and endothelium-dependent vasorelaxant 
properties of HDL particles are reduced (Vergès 2009b). 
Increases in the levels of palmitic acid, palmitoleic acid, and 
dihomo-γ-linolenic acid (DGLA), as well as low amount of 
linoleic acid have been associated with insulin resistance 
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(Vessby et al. 2002; Risérus et al. 2009). The trans fatty acid 
intake is also positively correlated with the risk of diabetes 
(Risérus et al. 2009). It has been proposed that trans fatty acids 
increase inflammatory cytokines that are related to the risk of 
diabetes (Mozaffarian 2006). 
1.6.3 Atherosclerosis 
Atherosclerosis is a chronic inflammatory condition, and it is the 
most common cause of myocardial infarction, stroke, and 
cardiovascular disease (Shibata & Glass 2010; Adibhatla & 
Hatcher 2010). Accumulation and oxidation of LDL in the 
arterial intima and recruitment of monocytes to the developing 
lesion are two critical events in atherogenesis (Adibhatla & 
Hatcher 2010; Moore & Tabas 2011). 
The first step in the atherosclerosis is endothelial dysfunction 
that is caused for example by elevated levels of LDL, 
hypertension, free radicals, or elevated homocysteine 
concentration. The endothelial dysfunction increases the 
adhesiveness and permeability of the endothelium and induces 
the production of cytokines and growth factors (Ross 1999). 
Inflammatory response then stimulates adhesion of monocytes 
to the endothelium (Mangge et al. 2010; Bornfeldt & Tabas 
2011). Monocytes penetrate into the arterial intima, differentiate 
into macrophages and eventually become foam cells by binding 
and endocytosing oxidized LDL (Lusis 2000; Maxfield & Tabas 
2005; Adibhatla & Hatcher 2010). The macrophage foam cells 
generate inflammatory mediators that recruit other cell types 
and contribute to the development of a complex lesion (Shibata 
& Glass 2010; Adibhatla & Hatcher 2010). The accumulation of 
mononuclear cells, migration and proliferation of smooth 
muscle cells, as well as the formation of fibrous tissue enlarge 
and restructure the lesion (Lusis 2000). Thickening of the artery 
wall can be compensated, to some extent, by dilatation of the 
blood vessel. However, at some point, the artery is no longer 
able to compensate the thickening and the blood flow of the 
artery is altered (Ross 1999). It is also possible that the lesion 
ruptures and causes thrombosis. The thrombus can block the 
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blood flow at the site of the thrombosis or, after erosion, the 
blood clot can move along the circulation and occlude a vein 
somewhere else (Lusis 2000). 
Atherosclerotic patients have shown to have elevated serum 
levels of oxysterols. Oxysterols regulate lipid metabolism and 
inflammation and are toxic factors contributing to clinical 
complications of atherosclerosis (Shibata & Glass 2010). 
Sphingolipids can promote atherosclerosis and thrombosis 
through several mechanisms. Ceramides of LDL particles tend 
to accumulate and self-aggregate to the artery walls (Holland & 
Summers 2008). This can induce foam cell formation. Ceramides 
are also able to induce apoptosis in vascular wall cells 
contributing to the erosion of plaques (Mallat & Tedgui 2001). 
S1P, the phosphorylated derivative of sphingomyelin, 
stimulates endothelial and smooth muscle cell proliferation that 
results in thickening of the vascular wall and plaque 
stabilization (Yatomi et al. 2000). 
1.6.4 Metabolic syndrome 
Metabolic syndrome is a collection of metabolic disorders and it 
is associated with an increased risk of development of type 2 
diabetes and cardiovascular disease (Devaraj & Jialal 2012). 
Nutrition has a major impact on the development of metabolic 
syndrome (Kawashima et al. 2009). The National Cholesterol 
Education Program’s Adult Treatment Panel III (NCEP ATP III) 
has defined metabolic syndrome as a state involving any three 
or more of the following risk factors: elevated TAGs, reduced 
HDL cholesterol, elevated fasting glucose, elevated blood 
pressure or obesity (Grundy et al. 2005; Gillingham et al. 2011). 
Metabolic syndrome is usually associated with insulin 
resistance, and insulin resistance is related with a certain FA 
composition of serum (Vessby 2003). Patients with metabolic 
syndrome tend to have low concentrations of linoleic acid and 
high concentrations of DGLA, palmitic, and palmitoleic acids 
(Kawashima et al. 2009). It has been suggested that the increase 
of MUFA intake, especially as a substitute for dietary saturated 
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FAs, promotes the reduction of traditional risk factors defining 
metabolic syndrome (Gillingham et al. 2011). 
Metabolic syndrome is also associated with disturbed 
lipoprotein metabolism (van Heyningen 2005; Suna et al. 2007). 
The level of HDL cholesterol is lower and HDL particles are 
smaller and denser than in healthy controls. Obesity and insulin 
resistance result in increased production of larger VLDL 
particles that leads to the formation of smaller and denser LDL 
particles (van Heyningen 2005). 
1.6.5 Alzheimer’s disease 
AD is a progressive neurodegenerative disorder which is 
characterized by amyloid-β (Aβ) plaques, neurofibrillary tangles 
composed of abnormally hyperphosphorylated tau protein, and 
neuronal cell loss (Cunnane et al. 2009; Adibhatla & Hatcher 
2010; Jicha & Markesbery 2010). Memory loss and cognitive 
decline are the clinical symptoms of AD (Hartmann et al. 2007). 
In sporadic late-onset AD (90–95% of all cases) the first 
symptoms appear after age of 65, and the presence of allele ε4 in 
the gene of apoE, which is the major carrier of cholesterol in 
central nervous system, is the main genetic risk factor. Familial 
early-onset AD starts approximately after 40 years of age and is 
associated with mutations in the genes coding amyloid 
precursor protein (APP) and presenilins 1 and 2. Several 
vascular problems such as atherosclerosis, hypercholesterolemia, 
diabetes, and obesity increase the risk of developing sporadic 
AD, whereas dietary antioxidants, B-vitamins, and ω-3 PUFAs 
may have potentially protective effects (Cunnane et al. 2009; 
Fonseca et al. 2010). 
Cholesterol has a role in the development and progression of 
AD (Reid et al. 2007; Adibhatla & Hatcher 2010). High 
cholesterol content in lipid rafts, where the APP processing 
takes place, favors amyloidogenic processing of the APP 
whereas low cholesterol content yields mainly non-
amyloidogenic Aβ production (Mathew et al. 2011). 
Furthermore, cholesterol is a precursor of neurosteroids of 
which many have neuroprotective functions. The levels of these 
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neurosteroids are decreased in AD brains (Adibhatla & Hatcher 
2010). 
Also sphingolipids have important functions in AD. 
Sphingomyelin inhibits γ-secretase leading to decreased Aβ 
production (Hartmann et al. 2007). Acid sphingomyelinase is 
activated in AD brain that leads to elevated ceramide levels, 
activation of ceramidases, and production of sphingosine. 
Ceramide promotes Aβ biogenesis, and thus, the reduction of 
ceramide levels reduces the secretion of APP and Aβ in human 
neuroblastoma cells. It has been suggested that elevated 
amounts of ceramide and sphingosine, as well as low S1P 
creates a “pro-apoptotic” environment in the AD brain leading 
to neuronal death (He et al. 2010). Additionally, some 
gangliosides bind Aβ peptides and alter their conformations 
from random coils to more ordered structures thus increasing 
their aggregation (Di Paolo & Kim 2011). 
The nervous system is highly enriched with PUFAs, 
especially DHA (Hartmann et al. 2007; Jicha & Markesbery 
2010). There has been evidence of the inverse correlation 
between the intake of DHA and AD incidence. For example, the 
daily administration of ω-3 FAs (DHA and EPA) resulted in 
positive effects in patients at very mild stage of AD, whereas no 
beneficial effects were observed in patients having mild-to-
moderate AD (Hartmann et al. 2007). In addition, the low 
relative amount of ω-3 FAs has been proposed to be indicative 
of mild cognitive impairment (MCI) that is a transitional state 
with considerably increased risk for AD (Tukiainen et al. 2008). 
Some studies suggest that the beneficial effects of ω-3 FA 
supplementation may depend on the stage of the disease, other 
dietary mediators, and apoE status. Also several mechanisms 
how ω-3 PUFAs may prevent amyloidogenic processing have 
been presented. These include the facilitation of α-secretase 
actions that leads to the release of non-toxic amyloid peptides, 
the shielding of γ-secretase cleavage site and the dysregulation 
of γ-secretase yielding prevention of Aβ peptides, and the 
inhibition of fibrillation and aggregation of Aβ fragments (Jicha 
& Markesbery 2010). 
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Also progressive inflammation and increased oxidative stress 
may have an important role in the early development of Aβ 
plaque deposition and tangle formation (Jicha & Markesbery 
2010). The accumulation of Aβ fragments induces inflammatory 
response and expression of pro-inflammatory cytokines. These 
cytokines again stimulate Aβ production and amyloid formation 
(Cunnane et al. 2009). EPA and DHA can protect from 
inflammation since the mediators formed from these FAs, such 
as leukotrienes and resolvins, are anti-inflammatory (Cunnane 
et al. 2009; Barberger-Gateau et al. 2011). The accumulation of 
Aβ peptides is also accompanied by increased free radical 
production and increased lipid peroxidation in the brain 
(Cunnane et al. 2009). 
1.7 ANALYSIS OF SERUM LIPIDS 
Prior to the analysis of lipids, they have to be extracted from 
serum to get rid of proteins and other non-lipid molecules. Since 
there are a lot of different lipids in serum, their analysis requires 
usually a combination of different fractionation and detection 
techniques. The following sections include descriptions of these 
commonly used methods used in lipid studies. 
1.7.1 Lipid extraction techniques 
There are four main extraction protocols for serum lipids. 
Extraction protocols of Folch (Folch et al. 1957), as well as the 
method of Bligh and Dyer (Bligh & Dyer 1959) use chloroform 
and methanol as solvents. The dichloromethane assay is based 
on the Folch method but chloroform is replaced by less 
carcinogenic dichloromethane (Cequier-Sánchez et al. 2008). The 
fourth protocol uses methyl-tert-butyl ether (MTBE) and 
methanol to extract lipids (Matyash et al. 2008). 
 
Folch method 
The Folch method is a widely known lipid extraction 
protocol that was initially developed to extract lipids from 
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various animal tissues (Folch et al. 1957). The method involves 
the homogenization of the tissue with a 2:1 chloroform-
methanol (v/v) mixture after which the extract is washed by 
adding 0.2 of its volume of either water or an appropriate salt 
solution (NaCl, KCl, CaCl2, or MgCl2) (Figure 18). The mixture 
forms two separate phases of which the lower organic phase 
contains lipids. The purpose of the salt solution is to reduce the 
dissolution of lipids to the water-methanol phase. 
 
Bligh and Dyer method 
The Bligh and Dyer method was developed to extract lipids 
from tissues containing 80% water and about 1% lipids (Bligh & 
Dyer 1959). In the protocol, a tissue sample is homogenized with 
a mixture of 2:1 methanol-chloroform (v/v) after which 
chloroform and water are added (Figure 18). Final ratios of 
methanol, chloroform, and water are 2:2:1.8. The additions of 
chloroform and water produce a biphasic system, of which the 
lower chloroform layer contains lipids and the upper methanol-
water phase non-lipid molecules. When extracting materials that 
do not contain 80% water, the size of the sample should be 
adjusted so that the volumes of chloroform, methanol, and 
water, before and after the final additions of chloroform and 
water, are in the proportions 1:2:0.8 and 2:2:1.8, respectively. 
 
Dichloromethane method 
The dichloromethane extraction method is based on the Folch 
protocol but chloroform has been replaced with 
dichloromethane (Cequier-Sánchez et al. 2008). The protocol 
involves the extraction of lipids with 2:1 dichloromethane-
methanol (v/v) (Figure 18). The assessment of the 
dichloromethane assay with different tissue samples indicated 
that the protocol yields comparable results with the Folch 
method, and thus, dichloromethane can replace chloroform in 
lipid studies (Cequier-Sánchez et al. 2008). 
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MTBE method 
In the extraction protocol of Matyash et al, lipids are 
extracted with 10:3:2.5 MTBE-methanol-water (v/v/v) (Figure 18) 
(Matyash et al. 2008). The solvent mixture forms two layers of 
which the upper one contains lipids. Using the MTBE protocol, 
the recovery of the lipid species of almost all major classes has 
been shown to be the same or better than is typically achieved 
by the Folch method (Matyash et al. 2008). 
 
Comparison of the extraction protocols 
Figure 18 shows the four extraction protocols described 
above. Even though the Folch and Bligh and Dyer extraction 
methods were initially developed for tissue samples, these 
protocols, or their variations, have been widely used also for the 
extraction of serum lipids (Burdge et al. 2000; Sommer et al. 
2006; Beger et al. 2006; Pietiläinen et al. 2007; Ding et al. 2008; 
Sandra et al. 2010; Sorensen et al. 2010). However, it has been 
proposed that the use of chloroform should be avoided since it 
is toxic and carcinogenic. Dichloromethane is a good alternative 
for chloroform since it is less toxic but extracts lipids as well as 
chloroform (Cequier-Sánchez et al. 2008). 
The biggest difference between the MTBE method and 
chloroform or dichloromethane based methods is that the 
density of MTBE is lower than that of water, and thus, it is the 
upper phase in the two-phase partitioning system whereas 
chloroform and dichloromethane are below the water phase 
(Figure 18). When the lower phase is collected, the glass pipette 
or the needle has to go through the protein layer which is 
between the two phases. Even minute amounts of insoluble 
precipitate can cause problems when using liquid 
chromatography or mass spectrometry (MS), and thus, when 
using these quantification methods, the MTBE protocol is 
preferred (Matyash et al. 2008). 
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Figure 18. Overview of the Folch, Bligh and Dyer, dichloromethane, and MTBE 
extraction protocols. For clarity, only one extraction cycle is presented. After removal 
of the organic phase, the water phase is usually extracted again with organic solvent to 
enhance the yield. CHCl3, chloroform; CH2Cl2, dichloromethane; CH3OH, methanol; 
MTBE, methyl-tert-butyl ether; O, organic phase; P, protein layer; W, water phase 
1.7.2 Lipid fractionation techniques 
After extraction, the lipid sample is often fractionated using 
chromatography. Chromatographic systems consist of a 
stationary and a mobile phase. The stationary phase can be solid 
or liquid, and the mobile phase is either gas or liquid. The 
separation of the sample components is based on their different 
physical and chemical properties since the molecules have 
different affinities for the two phases (Peterson & Cummings 
2006). Thin-layer chromatography (TLC), gas chromatography 
(GC), high-performance liquid chromatography (HPLC), and 
solid-phase extraction (SPE) are common separation methods 
for lipid mixtures. 
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Thin-layer chromatography 
Thin-layer chromatography is a simple, fast, and moderately 
cheap separation method that has been widely used in lipid 
research (Touchstone 1995; Fuchs et al. 2010). TLC utilizes a 
solid stationary phase and a liquid mobile phase (Peterson & 
Cummings 2006). In TLC method, a total lipid extract is 
dissolved usually in chloroform and applied to the origin of a 
TLC plate (Burdge et al. 2000). Silica gel, alumina, and 
kieselguhr are commonly used stationary phases for lipid 
separations, of which silica gel is the most popular (Fuchs et al. 
2011). It is also possible to make chemical modifications to the 
silica gel to improve the separation of the lipid classes (Peterson 
& Cummings 2006). 
Dried lipid spots are developed with appropriate mobile 
phase after which the plates are allowed to dry (Burdge et al. 
2000). Solvent mixtures of chloroform, methanol and water are 
common as mobile phases (Peterson & Cummings 2006). Lipid 
spots can be detected by staining and collected by scraping the 
silica into a glass tube (Burdge et al. 2000). There are various 
non-destructive and destructive dyes available (Fuchs et al. 
2011). Lipid spots are identified by calculating the retardation 
factor (Rf), which is the ratio of the distance moved by the 
analyte from the origin to the distance moved by the flowing 
solvent from the origin (Figure 19) (Peterson & Cummings 
2006). To obtain reliable identification for the lipid spots, a 
reference sample should also be applied to the plate since Rf 
values depend on different parameters such as solvent 
composition, used TLC plates, relative humidity, and 
temperature. Additionally, TLC is possible to couple with 
matrix assisted laser desorption ionization (MALDI) mass 
spectrometer (Fuchs et al. 2009). 
The separation of lipid classes can be improved by using two-
dimensional (2D) chromatography in which the TLC plate is 
first developed in one direction, and after drying, it is developed 
in another solvent mixture and the plate is turned 90° compared 
to the first development direction (Figure 19) (Singh & Jiang 
1995; Peterson & Cummings 2006). However, 2D TLC cannot be 
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used to analyze more than one sample per plate (White et al. 
1998; Fuchs et al. 2011). Also, as only a single sample can be 
applied, the simultaneous application of standards is not 
possible which complicates spot assignments and quantitative 
data analysis (Fuchs et al. 2011). 
 
 
 
Figure 19. Overview of the one-dimensional (1D TLC) and two-dimensional (2D TLC) 
thin-layer chromatography runs. Retardation factor (Rf) is defined as the ratio of the 
distance moved by the analyte from the origin (x) to the distance moved by the flowing 
solvent from the origin (y). 
 
An another variation of TLC, a multi-one-dimensional TLC 
(MOD-TLC) involves the separation of lipids by running the 
plate using several different solvent mixtures and drying the 
plate before changing the solvent (White et al. 1998). MOD-TLC 
allows for direct comparative analysis of multiple samples on a 
single TLC plate, and still provides good resolution for the 
quantification of most of the major lipid classes. There are 
MOD-neutral- and MOD-flip-flop-TLC methods which vary 
from each other by the used solvent mixtures and the place 
where the samples are applied on the plate. Additionally, in 
MOD-flip-flop-TLC, the TLC plate is rotated by 180° before the 
last solvent run (White et al. 1998). 
High-performance TLC (HPTLC) is an advancement of TLC 
method which exploits finer gel grades than normal TLC and 
allows plates to be thinner and smaller, thus leading to faster 
separation times and better separation efficiency (Peterson & 
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Cummings 2006; Stübiger et al. 2009). Furthermore, HPTLC 
requires smaller sample amounts, as well as smaller detection 
limits can be achieved when compared with normal TLC (Fuchs 
et al. 2011). 
 
Gas chromatography 
Gas chromatography can be used to separate volatile organic 
compounds (Roberts et al. 2008). Some of the lipids are naturally 
volatile but most of them must be derivatized to increase their 
volatility (Nelson & Cox 2000; Roberts et al. 2008). Thus, prior to 
GC-analysis, lipids are hydrolyzed and methylated to 
corresponding FA methyl esters (FAMEs) (Bicalho et al. 2008). 
GC includes a solid stationary phase and a gaseous mobile 
phase (Peterson & Cummings 2006). Polar stationary phases are 
usually used to separate complex FAME mixtures (Bicalho et al. 
2008). Non-polar silicone phase allows separation of FAMEs 
according to their molecular weight whereas high molecular 
weight hydrocarbon phase separates FAMES based on their 
unsaturation (Roberts et al. 2008). Helium is commonly used as 
a mobile phase (Bicalho et al. 2008; Novgorodtseva et al. 2011; 
Liu et al. 2011). There are different detectors that can be coupled 
to GC but flame ionization detection and mass spectrometer are 
commonly used in lipid studies (Dodds et al. 2005; 
Quehenberger et al. 2011). 
 
High-performance liquid chromatography 
High-performance liquid chromatography is a widely used 
separation method for lipids, and it can also be used for 
quantification when internal standards are available (Schiller et 
al. 2004). HPLC utilizes a solid or a liquid-coated solid 
stationary phase and a liquid mobile phase (Peterson & 
Cummings 2006). Also ultra-performance liquid 
chromatography (UPLC) is applied to lipid analysis. With UPLC 
it is possible to obtain chromatographic separations in shorter 
analytical run than with HPLC without losing specificity and 
fidelity (Castro-Perez et al. 2010). 
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HPLC can be divided in two groups on the basis of the 
polarities of the stationary phase and the mobile phase: normal-
phase HPLC (NP-HPLC) and reverse-phase HPLC (RP-HPLC). 
In NP-HPLC the stationary phase is more polar than the mobile 
phase whereas in RP-HPLC the mobile phase is more polar than 
the stationary phase (Peterson & Cummings 2006). For example, 
when separating phospholipids, NP-HPLC separates PLs 
according to their head group whereas RP-HPLC allows 
separation based on the hydrophobicity of the FA residues 
(Schiller et al. 2004; Castro-Perez et al. 2010; Khalil et al. 2010). 
Common detectors coupled to HPLC that are used for lipid 
studies include ultraviolet (UV) detector, light scattering 
detector (LSD), and mass spectrometer (Roberts et al. 2008). UV 
detectors are highly sensitive but saturated FAs are under-
represented since only carbonyl groups and double bonds are 
functional groups that absorb in the UV range (Peterson & 
Cummings 2006). LSD measures the intensity of light scattered 
by lipids that remain after the solvent has been evaporated 
(Wang et al. 2003). LSD is not dependent on the degree of 
saturation of the FAs in the sample like UV detectors but the 
detector is destructive and each lipid class needs to be calibrated 
separately to quantify lipids (Peterson & Cummings 2006). MS is 
nowadays the most popular detection method and it is further 
discussed later. 
 
Solid-phase extraction 
SPE is a column chromatography method in which the 
analytes form strong but reversible interactions with the 
stationary phase of the column and the compounds are 
separated by washing the column with different solvents (Ruiz-
Gutiérrez & Pérez-Camino 2000). There is a wide range of 
chemically bonded stationary phases commercially available but 
the most suitable phases for the separation of lipid classes are 
aminopropyl bonded phases (Burdge et al. 2000; Bondia-Pons et 
al. 2006). 
In SPE, the columns are placed in vacuum and activated with 
an appropriate solvent mixture. Lipid extracts dissolved in 
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chloroform are applied to the cartridges under vacuum and the 
solvent is pulled through, thus leaving the lipid mixture on the 
column (Bondia-Pons et al. 2006). The column is washed with 
different solvents to separate different lipid classes (Kaluzny et 
al. 1985; Bondia-Pons et al. 2006). In Figure 20 is shown how 
FFAs, PLs, and neutral lipids can be separated using SPE. Since 
the recovery of lipid classes is less than 100%, appropriate 
recovery standards should be included into the samples for the 
determination of lipid concentrations (Burdge et al. 2000). 
 
 
 
Figure 20. Separation of phospholipids (PLs), free fatty acids (FFAs) and neutral 
lipids (NLs) including free cholesterol, esterified cholesterol, triacylglycerides, 
diacylglycerides, and monoacylglycerides by solid-phase extraction (Kaluzny et al. 
1985). Lipid extract is first dissolved in chloroform, and then the mixture is applied to 
the column. Chloroform is pulled through thus leaving the lipids on the column (A). 
The column is eluted with 2:1 chloroform-2-propanol to separate neutral lipids (B). 2% 
acetic acid in diethyl ether is used to separate FFAs from PLs (C), and finally, PLs are 
removed from the column by adding methanol (D). 
 
Comparison of the fractionation methods 
The advantages and drawbacks of TLC, GC, HPLC, as well as 
SPE are shown in Table 6. TLC is ecologically-friendly method 
since low amounts of solvents are needed especially in 
comparison with HPLC (Fuchs et al. 2010). SPE resembles TLC 
since both of them are able to separate lipid mixtures into 
different lipid classes (Bondia-Pons et al. 2006). HPLC is 
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relatively fast and it has high resolution (Schiller et al. 2004). GC 
requires the lipids to be volatile, and thus, polar lipids need to 
be derivatized (Wenk 2005). Both GC and HPLC can be 
automated and combined with mass spectrometer (Fuchs et al. 
2011). 
 
Table 6. The advantages and drawbacks of thin-layer chromatography (TLC), gas 
chromatography (GC), high-performance liquid chromatography (HPLC), and solid 
phase extraction (SPE) (Wenk 2005; Khalil et al. 2010; Fuchs et al. 2011). 
 
Method Advantages Drawbacks 
TLC - inexpensive 
- low amounts of solvents 
- technically easy 
- suitable for complex 
mixtures 
- different staining 
- possible to couple with 
MALDI 
- oxidation of unsaturated FAs may 
occur 
- not automated 
- relatively poor reproducibility 
- low lipid recoveries 
GC - highly established in FA 
analysis 
- automatic devices 
commercially available 
- coupling with mass 
spectrometer 
- derivatization required since only 
volatile compounds can be analyzed 
- large amount of lipids required for 
derivatization 
- yield information on the hydrolysis 
products of lipids and not on the 
parent compounds 
HPLC - high quality separations 
achievable 
- separated fractions can be 
collected and used for 
further analysis 
- automated 
- coupling with mass 
spectrometer 
- detection of saturated lipids difficult 
when using UV detector 
- post-column derivatization 
challenging 
SPE - quite inexpensive 
- versatile 
- technically easy 
- recovery standards required for 
quantification 
- not automated 
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1.7.3 Lipid quantification techniques 
TLC, GC, and HPLC are mainly lipid separation methods but 
they can also to some extent be used for quantification of lipids. 
However, MS and nuclear magnetic resonance (NMR) 
spectroscopy are preferable methods for lipid identification and 
quantification. 
 
Mass spectrometry 
Mass spectrometric analysis includes a production of gas-
phase ions from analyte compounds, a separation of the formed 
ions according to their mass-to-charge ratio (m/z), and a 
detection of ions in proportion to their abundance (Roberts et al. 
2008). It is also possible to fragment the precursor ion which is 
useful especially in identification of the compounds. This 
method is called tandem MS (MS/MS) (de Hoffmann & 
Stroobant 1999). There are many types of mass spectrometers 
that differ in the type of ionization source and mass analyzer 
(Peterson & Cummings 2006). 
Ionization sources can be divided into hard and soft 
ionization methods based on the extent of fragmentation of the 
molecule. Hard ionization methods, such as electron ionization, 
yield a lot of fragments whereas soft ionization techniques, such 
as electrospray ionization (ESI) and MALDI, result in only a few 
fragmentations and usually the molecular ion is present in the 
mass spectrum (Peterson & Cummings 2006). The soft ionization 
methods are preferred in modern lipid analysis (Schiller et al. 
2004). 
ESI is an ion source which ionizes a sample at atmospheric 
pressure. The sample is directed through a narrow hole in the 
ion source creating a spray. The spray is ionized, and eventually 
the solvent evaporates and charge is applied to the sample (de 
Hoffmann & Stroobant 1999; Peterson & Cummings 2006). ESI 
generates usually protonated or deprotonated molecules 
depending on the polarity of the ionization mode utilized. It can 
also generate molecular adducts with cations such as Na+, K+ or 
NH4+ in positive ion mode which originate mainly from the 
mobile phase used for the analysis (Castro-Perez et al. 2010). 
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ESI is usually coupled to time-of-flight (TOF) (Sandra et al. 
2010) or ion-trap (Hu et al. 2008; Pang et al. 2008; Ding et al. 
2008; Sorensen et al. 2010) mass analyzers. ESI-MS is suitable for 
sensitive, quick, and high-throughput qualitative and 
quantitative determination of lipid mixtures (Table 7), especially 
PLs, since ESI-MS has a simple sample processing approach, 
good resolution, and it can be automated (Zhu et al. 2009). 
Using ESI-MS it is possible to characterize and quantify 
substances even in femtogram levels (Castro-Perez et al. 2010). 
MALDI ion source requires that the sample is crystallized 
with a matrix that absorbs light at the laser wavelength (Fuchs 
et al. 2010). Small organic molecules are usually used as a 
matrix, and 2,5-dihydroxybenzoic acid (DHB) has proposed to 
be the most appropriate matrix for lipid analysis. By using DHB, 
both positive and negative ion mass spectra can be recorded 
from the same sample. Lipid analysis by MALDI is usually 
performed using N2 lasers (Schiller et al. 1999; Schiller et al. 
2004). When the vaporized gas cloud expands, ions (e.g. H+ and 
Na+) are exchanged between the matrix and the analyte, thus 
leading to the formation of charged analyte molecules which are 
called adducts or quasimolecular ions. Also anions can be 
generated by abstracting H+ or Na+ from the analyte. Positive 
and negative ions can be differentiated by inverting the 
direction of the applied electric field. To record positive-ion 
mode spectra is more common and it has been noted that 
MALDI mass spectrometers detect negative ions less sensitively 
than positive ions (Fuchs et al. 2009; Fuchs et al. 2010). 
MALDI ion source is normally combined with a TOF mass 
analyzer since TOF has a nearly unlimited mass range and the 
pulsed ion generation of MALDI is most suitable for TOF (Fuchs 
et al. 2010). MALDI-TOF MS allows the analysis of lipids in 
nanomolar range (Schiller et al. 2004). The advantages of 
MALDI-MS are the speed of analysis and simplicity of operation 
(Zehethofer & Pinto 2008; Hu et al. 2009). However, the matrix 
molecules cause a lot of background in the lower mass range 
which is an important disadvantage of the method (Table 7). 
MALDI can be coupled also with Fourier transform ion 
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cyclotron resonance MS (FTICR-MS) which solves the problem 
arising from the matrix background because the matrix peaks 
and lipids are resolved due to the high resolution of FTICR. 
FTICR has also better mass accuracy, sensitivity, and MS/MS 
capabilities than MALDI-TOF MS but the acquisition time is 
slower. MALDI-MS-based methods have limitations such as 
quantification of complex mixtures, and when compared with 
ESI-MS, MALDI-MS is less quantitative (Table 7) (Hu et al. 
2009). 
 
Table 7. The advantages and drawbacks of electrospray ionization (ESI) and matrix 
assisted laser desorption ionization (MALDI) (Wenk 2005; Hu et al. 2009). 
 
Ionization Advantages Drawbacks 
ESI - direct detection by m/z 
- high sensitivity and resolution 
- direct profiling of complex lipid 
mixtures 
- ease of automation 
- compatible with HPLC and GC 
- quantification in femtogram level 
- suppression of ionization 
- absolute quantification 
laborious 
MALDI - direct detection by m/z 
- buffer and salt contaminants 
generally well tolerated 
- can be combined with prior TLC 
separation 
- fast 
- simple 
 
- suppression of ionization 
- matrix backgrounds 
- less quantitative than ESI-
MS 
- quantification of complex 
mixtures difficult 
- quantification of lipids in 
nanomolar range 
 
Before MS analysis the sample is usually pre-fractionated 
using liquid chromatography (Pang et al. 2008; Sandra et al. 
2010; Sorensen et al. 2010), TLC (Fuchs et al. 2009), GC (Zhu et 
al. 2009) or SPE (Burdge et al. 2000) since different lipid classes 
have different desorption/ionization characteristics which cause 
suppression effects thus making the analysis difficult or the 
interpretation of the results complicated. The fractionation 
  79 
 
significantly improves the lipid detection and allows more 
accurate peak assignments and easier quantification (Stübiger et 
al. 2009). However, the fractionation can weaken the accuracy 
since the yields of different lipid species obtained by using 
diverse fractionation methods may vary unless also yield 
standards are used. 
There is also a direct infusion ESI-based MS approach that 
involves a direct infusion of a crude lipid extract or a fraction 
obtained after further sample preparation into the MS without 
pre-fractionation (Han et al. 2012). A drawback of this method is 
that the resolution of the lipids with the same molecular weight 
(isobaric lipids) is limited if MS/MS experiments are not used 
and there is a risk of ion suppression of very low abundant 
lipids (Hu et al. 2009). 
The quantification with MS requires the use of internal 
standards. Especially when using MALDI, there is a direct 
relation between signal intensity and analyte concentration only 
in a small concentration range. Thus, similarly concentrated 
analyte solutions should be used and all the measurements 
should be performed in the presence of internal standards 
(Fuchs et al. 2010). The internal standard should belong to the 
same lipid class as the compound that is investigated and have a 
comparable molecular weight (Schiller et al. 2004). Isotopically 
labeled compounds or lipids with odd numbered fatty acyl 
chains are commonly used as internal standards in lipid 
samples. It is also possible to use relative peak intensity ratios 
for the quantification but it does not reveal whether only one or 
both concentrations are changing, and thus, the use of internal 
standards is recommended (Fuchs et al. 2010). Lipids can also be 
quantified by using a signal-to-noise ratio (S/N) that is 
calculated according to Eq. 1 (Müller et al. 2001). 
 
  S/N = 2.5[(SH – 0.5NPP)/NPP],   (1) 
 
where SH is the signal height at the center of a certain mass peak 
over the lower limit of noise (Figure 21). NPP is the peak-to-peak 
80   
 
noise amplitude, determined from the maximum and minimum 
values of 250 points of pure noise (Figure 21). 
 
 
Figure 21. Hypothetical mass 
spectrum showing the signal height of 
a certain peak over the lower limit of 
noise (SH) and the peak-to-peak noise 
amplitude (NPP) that are used for the 
calculation of the S/N ratio from the 
MS spectrum as shown in Equation 1. 
 
NMR spectroscopy 
NMR spectroscopy is based on the behavior of magnetically 
active nuclei in magnetic field (Günther 1995). The nuclei are 
excited with a radiofrequency pulse after which they start to 
return to their ground state and the emission signal i.e. free 
induction decay (FID) is detected (Fessenden et al. 1998; 
Claridge 1999). FID describes the intensity of the detected signal 
as a function of time. FID is then Fourier transformed to give a 
spectrum in which the signal intensities are presented as a 
function of frequency (Claridge 1999). Chemical shifts of the 
resonance signals are usually reported in δ values, which are 
expressed as parts per million (ppm) of the applied 
radiofrequency (Fessenden et al. 1998). For example, at 
500 MHz, 1.0 ppm is 500 Hz. 
Prior to NMR measurement, the sample has to be dissolved 
in a deuterated solvent that serves as a lock signal to maintain 
the field stability. Normally a chemical shift reference 
compound is added to the sample (Claridge 1999). In the NMR 
spectrum, the area under a resonance signal is proportional to 
the number of nuclei that give rise to the signal (Figure 22) 
(Beyer et al. 2010; Srivastava et al. 2010a). The signal areas can 
be transformed to concentrations by using an internal or 
external concentration reference compound. If a concentration 
reference is not used, the relative quantification can be 
performed by using ratios of selected resonances (Kriat et al. 
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1993). The acquisition parameters, such as pulse width, 
acquisition time, relaxation delay, spectral width, transmitter 
offset, and number of scans and dummy scans should be 
selected in a way that the spectrum provides quantitative 
information (Beyer et al. 2010). 
NMR spectroscopy has several advantages over MS-based 
approaches (Oostendorp et al. 2006). NMR does not require 
many different standard compounds, the identification and 
quantification of lipids are almost unequivocal if at least one 
distinct resonance is resolved and the sample preparation is 
simple (Oostendorp et al. 2006; Srivastava et al. 2010a). In 
addition, NMR spectroscopy does not require extensive 
optimization of instrumental parameters that are often needed 
in mass spectrometry. However, the quantification of 
metabolites from complex mixtures can be difficult if the signals 
are severely overlapping. Additionally, NMR is less sensitive 
(quantification in micromolar range) than MS-based approaches 
(Hu et al. 2009). 
 
 
 
Figure 22. 1H NMR spectrum (500 MHz) of methyl linoleate in deuterated chloroform 
with signal assignments. Chemical shifts (ppm) are referenced to tetramethylsilane 
(ref). The signal areas are shown on the top of each signal. 
 
1H, 13C, and 31P are the most useful nuclei in the biological 
NMR studies, and 1H is the most sensitive naturally occurring 
NMR nucleus due to its high gyromagnetic ratio and 100% 
abundance (Claridge 1999; Srivastava & Govil 2001). Tritium has 
even higher gyromagnetic ratio than proton but its natural 
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abundance is negligible (3 × 10-16%) (Yuen et al. 2010). The one-
dimensional (1D) 1H NMR spectrum of untreated serum does 
not provide much information on lipid molecules since they are 
mainly situated in the lipoprotein particles, and broad protein 
signals obscure their resonances (Oostendorp et al. 2006). 
However, this kind of spectrum can be used to quantify 
lipoprotein subclasses (Ala-Korpela et al. 2007). 1H NMR-based 
method for the quantification of lipoprotein subclasses was 
developed in 1990s (Otvos et al. 1992; Ala-Korpela et al. 1994). 
There is a commercial protocol called NMR LipoProfile® (by 
LipoScience Inc.) which provides information on 9 lipoprotein 
subclasses (Jeyarajah et al. 2006). There is also a corresponding 
assay that is able to quantify 14 lipoprotein subclasses 
(chylomicrons and extremely large VLDL particles, very large 
VLDL, large VLDL, medium VLDL, small VLDL, very small 
VLDL, IDL, large LDL, medium LDL, small LDL, very large 
HDL, large HDL, medium HDL, and small HDL) (Inouye et al. 
2010). Additionally, concentrations of several lipid groups in the 
lipoprotein subclasses (e.g. VLDL-TAGs, LDL-cholesterol, and 
HDL-cholesterol) can be determined (Vehtari et al. 2007; 
Kettunen et al. 2012). The quantification of both lipoprotein 
subclasses and the lipids in lipoproteins are obtained by a 
quantification protocol utilizing regression models. The models 
are cross-validated against NMR-independent HPLC data 
(Kettunen et al. 2012). 
The extraction of the lipids from serum makes it possible to 
quantify individual lipid species. 1D 1H NMR spectrum of a 
serum lipid extract provides, for example, concentrations of free 
and esterified cholesterol, TAGs, glycerophospholipids, PC, and 
SM (Tukiainen et al. 2008). Also, at least two FAs, linoleic acid 
and DHA, can be quantified (Willker & Leibfritz 1998; 
Tukiainen et al. 2008). Furthermore, methyl (CH3), methylene 
(-CH2-), allylic (=CH-CH2-), olefinic (-CH=CH-), and bisallylic 
(=CH-CH2-CH=) signals can be identified (Oostendorp et al. 
2006). The ratios of these signals have been used to estimate the 
mean FA chain length (methylene/bisallylic) (Kriat et al. 1993), 
the number of double bonds (methylene/olefinic) (Kriat et al. 
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1993), and the presence of branched chain FAs 
(methylene/methyl) (Oostendorp et al. 2006). It should be noted 
that the contribution of cholesterol protons have to be taken into 
account whenever they overlap with other signals (Roncalli et 
al. 2007). 
13C has low abundance (1.1%), and its gyromagnetic ratio is 
one-quarter of that of 1H, and thus, the overall sensitivity of a 
13C NMR measurement is approximately 0.01% of a proton 
spectrum of the same sample (Srivastava & Govil 2001). 
However, 13C NMR spectra are useful especially in identification 
of lipids since carbon chemical shifts are spread about 200 ppm 
range compared with narrow range of proton chemical shifts 
(approximately 10 ppm) (Pollesello et al. 1996; Srivastava & 
Govil 2001). Furthermore, the resonances that are severely 
overlapping in the 1D spectrum can be resolved and identified 
by homonuclear (1H-1H) or heteronuclear (1H-13C) 2D NMR 
(Srivastava & Govil 2001). 
31P is naturally abundant nucleus (100%), and the assignment 
of 31P resonances is quite simple since the chemical shift range of 
biological phosphates is large (approximately 40 ppm) 
(Srivastava & Govil 2001). In lipid studies, 31P NMR is suitable 
for PL analysis (Kriat et al. 1993; Wenk 2005; Srivastava et al. 
2010b; Fuchs et al. 2011). The main PLs of serum include PC, 
SM, and LPC, and they give separate resonance signals to a 31P 
NMR spectrum. Less abundant phospholipids, such as PS and 
PE, are usually not detected in a reasonable time (Kriat et al. 
1993). When measuring 31P NMR spectra, a suitable detergent 
can be added to the sample to suppress the aggregation of PLs 
that would cause line-broadening and loss of resolution (Fuchs 
et al. 2011). 
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2 Aims of the study 
This thesis introduces novel protocols for 1H NMR analysis of 
serum lipids. The development of the protocols was performed 
in the NMR metabonomics laboratory at the University of 
Eastern Finland, and the developed protocols have already been 
applied to numerous studies. The specific aims of this thesis 
were: 
 
1. To learn to perform modern quantum mechanical spectral 
analyses by analyzing the 1H NMR spectra of n-alkanes, as 
well as to understand the conformational behavior of CH2-
fragments, common structural units in lipids, in a solution 
state via the NMR spectral parameters of n-alkanes (Paper I) 
2. To develop and optimize an extraction protocol for serum 
lipids that allows the extraction of about 100 samples per 
day 
3. To develop a constrained total-line-shape (CTLS) fitting 
protocol to be used in the quantification of the 1H NMR 
spectra of serum lipid extracts (Paper II) 
4. To apply the lipid extraction and quantification protocols to 
clinical studies. The first study included patients with MCI 
(Paper II), and the second type 1 diabetic patients with 
concomitant kidney disease (Paper III) 
5. To develop an NMR-based protocol for the assessment of 
the serum lipid oxidation susceptibility (Paper IV) 
6. To apply the NMR oxidation protocol to serum samples 
from a chocolate consumption study (Paper IV) 
86   
 
  87 
 
3 Materials and methods 
3.1 SAMPLE POPULATIONS 
The extraction protocol for serum lipids was developed using 
fasting serum obtained from healthy volunteers. The serum 
samples were stored at -70°C. The study populations of the MCI, 
diabetes, and oxidation studies are defined below. 
3.1.1 Sample population of the MCI study (II) 
A total of 806 elderly individuals were recruited from Kuopio, 
Finland, between October 1997 and November 1998 to 
determine the prevalence of MCI among elderly population 
(Hänninen et al. 2002). The participants without dementia were 
followed-up at approximately 3, 5, and 6 years after the baseline 
visit. Altogether 45 individuals completed the full 6 years of 
follow-up and this group was included in the study. On each 
visit the participants underwent a structured interview 
including demographic and medical information, as well as an 
extensive neuropsychological assessment. The diagnosis of MCI 
was based on the diagnostic criteria proposed by Mayo Clinic 
Alzheimer’s Disease Research Center (Hänninen et al. 2002). At 
baseline two of the participants had MCI, and on the following 
visits the number of MCI subjects was 18, 16, and 18. At the last 
visit one of the subjects received a dementia diagnosis. Weight, 
height, and blood pressure were measured, and fasting blood 
samples were drawn at each visit. 
3.1.2 Sample population of the diabetes study (III) 
Altogether 326 type 1 diabetic patients (218 men and 108 women) 
as part of the Finnish Diabetic Nephropathy Study were 
included in the study (Mäkinen et al. 2008). Type 1 diabetes was 
defined as an age of onset below 35 years. About half (56%) of 
the study population did not have kidney disease and the rest 
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had microalbuminuria (17%) or overt kidney disease (26%). 
Serum and urine samples were collected from each study 
subject. 
The normal range of urinary albumin excretion rate (AER) 
was defined as AER < 20 μg/min for night urine or 
AER < 30 mg/24h for a timed circadian collection. The limits for 
overt kidney disease were: AER ≥ 200 μg/min or 
AER ≥ 300 mg/24h (macroalbuminuria). The intermediary range 
(microalbuminuria, 20 ≤ AER < 200 μg/min or 
30 ≤ AER < 300 mg/24h) is a clinically challenging borderline 
with no clear pathological changes. In this study, 
microalbuminuria was regarded as not having kidney disease, 
since reduced kidney function could not be seen. Since there can 
be a large daily variance in the AER values, the kidney 
diagnosis was based on at least two out of three consecutive 
albumin tests. Urinary albumin was measured also centrally 
from a single 24 h collection to obtain a continuous renal status 
(denoted by 24 h-AER). 
3.1.3 Sample population of the chocolate study (IV) 
The study population consisted of 45 non-smoking subjects (12 
men and 33 women) who had consumed 75 g of white chocolate 
(WC), dark chocolate (DC) or high-polyphenol chocolate (HPC) 
daily for three weeks (Mursu et al. 2004). There were 15 subjects 
in each chocolate group. The study subjects had to fulfill 
following criteria: (i) BMI < 32 kg/m2; (ii) no regular use of any 
drugs or supplements with antioxidative (β-carotene, vitamins 
C or E) or lipid-lowering properties; (iii) no chronic diseases 
such as diabetes, coronary heart disease, or other major illnesses; 
and (iv) willingness to consume 75 g of study chocolate daily for 
3 weeks. Fasting blood samples were taken before and after the 
chocolate consumption. The serum samples were stored at -70°C 
and not thawed before. 
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3.2 SAMPLE PREPARATION 
3.2.1 Preparation of the n-alkane samples (I) 
Approximately 5% (w/v) samples of liquid n-pentane, n-hexane, 
and n-heptane were prepared by dissolving the alkanes in 
deuterated chloroform. The n-butane sample was prepared by 
dissolving gaseous n-butane in deuterated chloroform. In 
addition, both n-pentane and n-hexane were dissolved in 
deuterated benzene, acetone, methanol, and dimethylsulfoxide 
(DMSO). For n-pentane, also acetonitrile and dichloromethane 
were used as solvents, and n-hexane was dissolved in 
hexane-d14. The samples were filtered through cotton wool to 
5 mm NMR tubes in order to get rid of possible solid particles, 
and oxygen in the NMR tubes was replaced with nitrogen. The 
solvents contained 0.03% of tetramethylsilane that served as an 
internal chemical shift reference. 
3.2.2 Preparation of the lipid samples 
Approximately 5% (w/v) samples of hexanoic acid (6:0), palmitic 
acid, oleic acid, palmitoleic acid, linoleic acid, DGLA, 
arachidonic acid, α-linolenic acid, EPA, DHA, PC, SM, TAG, as 
well as free and esterified cholesterol were prepared by 
dissolving the lipids in deuterated chloroform. 
Tetramethylsilane was used as an internal chemical shift 
reference. 
3.2.3 Extraction of lipids (II, III, IV) 
Serum lipids were extracted by using a dichloromethane 
(Cequier-Sánchez et al. 2008) method with some in-house 
modifications. Briefly, 1:2 (v/v) methanol-dichloromethane 
solution and an equal amount of 0.15 M NaCl solution were 
added to a serum sample. The sample was mixed and 
centrifuged (2200×g 20 min (II and III), or 2400×g 10 min (IV)) 
after which the lower dichloromethane layer was recovered. The 
remaining aqueous phase was extracted again with 
dichloromethane. The separated organic phases were combined 
and evaporated to dryness. The lipids were dissolved in 0.6 ml 
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of deuterated chloroform containing 0.03% tetramethylsilane for 
chemical shift reference. 
3.2.4 Oxidation of lipids (IV) 
First, 0.3 ml of serum, 0.3 ml of NMR buffer (75 mM Na2HPO4 in 
80%/20% H2O/D2O, pH 7.4; including also 0.08% sodium 
3-(trimethylsilyl)propionate-2,2,3,3-d4 and 0.04% sodium azide) 
(Soininen et al. 2009), and 0.3 ml of 0.15 M sodium chloride 
solution were combined in a 2 ml eppendorf tube after which 
the solution was warmed in an incubator at 37°C for 10 min. 
Oxidation reaction was initiated by adding 0.1 ml of 5, 10, 20 or 
40 mM CuSO4 to the prewarmed solution to yield a copper 
concentration of 0.5, 1.0, 2.0 or 4.0 mM, respectively. In order to 
determine the initial concentration of PUFAs in each sample, 
also a reference sample without copper was prepared. The 
copper containing samples were incubated in an end-over-end 
mixer at 37°C for 1.5, 3, 4.5 or 6 h. The optimized oxidation 
protocol included 0.5 M CuSO4 and 6 hour incubation. The 
oxidation reaction was terminated by extracting the lipids as 
described above. 
To be able to evaluate the repeatability of the method, five 
replicate samples were prepared within a period of two months 
in random order. The chocolate study samples were analyzed in 
triplicates (WC and HPC groups) or duplicates (DC group). 
3.3 NMR SPECTROSCOPY (I, II, III, IV) 
The 1H NMR measurements of all the studies were performed 
on a Bruker AVANCE 500 DRX spectrometer operating at 
500.13 MHz. Some of the spectra of the n-alkane study were 
measured with a Bruker AVANCE III spectrometer operating at 
500.36 MHz. Shimming of the n-alkane samples was performed 
manually paying attention to both linewidth and lineshape. The 
n-alkane spectra were measured with spinning the sample. The 
samples of the other studies were shimmed automatically 
  91 
 
without spinning the sample. Acquisition parameters used in 
each study are shown in Table 8. 
 
Table 8. Acquisition parameters used in the measurements of n-alkanes (I), hexanoic 
acid, individual lipid species, as well as MCI (II), diabetes (III), and chocolate (IV) 
studies. 
 
Parameter I and hexanoic 
acid 
individual 
lipid species 
II and III IV 
T (K) 300 293 293 295 
pulse sequence zg zg zg zg 
pulse angle (°) 90 90 90 90 
sw (Hz) 5530 3230 5340 4400
td 262144 65536 65536 65536
ds 0 0 4 2 
ns 8 1 64 64 
aq (s) 23.7 10.1 6.1 7.5 
d1 (s) 10.0 3.9 3.9 0.5 
aq, acquisition time; d1, relaxation delay; ds, number of dummy scans; ns, 
number of scans; sw, spectral width; td, number of data points 
 
All the spectra were processed using PERCH NMR Software 
(Laatikainen et al. 2011). The measured FIDs were zero-filled 
and multiplied by an exponential window function with a 
0.3 Hz (II and III) or a 0.5 Hz (IV and individual lipid species) 
line-broadening. The FIDs of the n-alkanes (I) and hexanoic acid 
were multiplied by a sinusoidal (Asin2x + Bey) window function 
prior to Fourier transformation to narrow the linewidths in 
order to be able to reveal the information arising from small 
coupling constants. 
3.4 QUANTUM MECHANICAL SPECTRAL ANALYSIS 
3.4.1 Spectral analysis of the 1H NMR spectra of n-alkanes (I) 
The spectral analyses of n-butane, n-pentane, n-hexane, and 
n-heptane were performed with PERCH NMR Software 
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(Laatikainen et al. 2011) using total-line-shape (TLS) fitting 
(Laatikainen et al. 1996a) mode of the PERCHit iterator. The 
geminal (2J) coupling constant of n-butane could not be obtained 
from the spectrum, and therefore, the value was estimated on 
the basis of the analysis of n-pentane spectrum and the value 
was kept fixed during the iteration. The spectral analyses of 
n-hexane and n-heptane were performed including only 2J, 3J, 
and 4J coupling constants since the spectra did not contain 
enough information about 5J and 6J couplings. 
Also baseline parameters were optimized during the 
iteration. The baseline correction compensates mainly lineshape 
artifacts that are due to the resolution enhancement which 
reduces the relative intensity of the central parts of the CH2 
signals. Since essential information on the coupling constants is 
carried by weak lines, some of the fittings were performed using 
a weighting function that gives higher weight for the smaller 
signals than for bigger ones. 
The spectral analyses of n-butane, n-pentane, and n-heptane 
were performed allowing different linewidths for each spin 
particle. In the case of n-hexane, the 2J coupling constants 
correlated with linewidths and had only a weak effect on the 
spectrum, and hence, the following approach was used. The 
geminal coupling constants were estimated on the basis of the 
spectral analysis of n-pentane and were kept fixed during the 
iteration. The fitting was started using the same linewidth for 
each spin particle and after convergence was achieved, the 
linewidths were released. 
3.4.2 Spectral analysis of the 1H NMR spectrum of hexanoic 
acid 
The spectral analysis of hexanoic acid was performed with 
PERCH NMR Software (Laatikainen et al. 2011) using both 
integral transform (Laatikainen et al. 1996a) and TLS fitting 
(Laatikainen et al. 1996a) modes of the PERCHit iterator. The 
starting values for the analysis were estimated based on the 
analyses of the n-alkane spectra. The 5J and 6J coupling constants 
were set to zero since the spectrum did not contain enough 
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information to solve them. The spectral analysis was started 
using integral transform mode, and the spectral parameters 
were finalized using TLS fitting mode. 
3.5 QUANTIFICATION OF SERUM LIPIDS BY TOTAL-LINE-
SHAPE FITTING (II, III, IV) 
The areas of the lipid resonances were determined using TLS 
fitting mode of PERCH NMR software (Laatikainen et al. 2011). 
The structures of some multiplets, which were defined by the 
intensity ratios, coupling constants, and frequencies of 
individual signals forming the multiplet, were used as 
constraints that enabled the quantitative analysis of severely 
overlapping peaks (Soininen et al. 2005). More detailed 
description of the analysis is provided in the Results and 
discussion section. 
3.6 CALCULATION OF THE NMR OXIDATION SUSCEPTIBILITY 
(IV) 
The NMR oxidation susceptibility was determined from the 
signal areas of the bisallylic protons of PUFAs (APUFA) at 2.74–
2.88 ppm. First, the difference between the amounts of PUFAs 
before (REF) and after (OX) the oxidation reaction was 
calculated. Then, the difference was divided by the signal area 
of PUFAs from the spectrum of non-oxidized sample and 
converted to a percentage value ((APUFA(REF)-
APUFA(OX))/APUFA(REF)×100%). The obtained value describes the 
amount of oxidized PUFAs, and hence, the oxidation 
susceptibility of serum lipids. The signal areas were scaled so 
that the signal area of total cholesterol C(18)H3 protons was the 
same both in the spectra of non-oxidized and oxidized serum. 
Also cholesterol oxidizes slightly and many of the cholesterol 
oxidation products can be identified from the spectrum of 
oxidized serum since their C(18)H3 signals resonate at 0.61–
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0.69 ppm, next to the non-oxidized cholesterol C(18)H3 signals 
(0.676 and 0.678 ppm) (Bradamante et al. 1992). These oxysterol 
signals were taken into account when the total cholesterol 
amount was calculated. 
3.7 DATA ANALYSIS 
3.7.1 Statistics of the oxidation study (IV) 
The results are expressed as means (± standard deviations). A 
paired t-test was used to test the changes between the baseline 
and end-point values within the study groups. Means were 
compared across the study groups by the analysis of variance 
(ANOVA), and post hoc Tukey’s test was used when a 
statistically significant heterogeneity between the groups was 
shown by the ANOVA. Correlations were estimated by 
Pearson’s or Spearman’s correlation coefficients. Differences 
with p values of 0.05 or less were considered significant. The 
statistical analyses were performed with SPSS software (version 
14.0; SPSS, Inc., Chicago, IL, USA). 
Random forest classification was used to study the chocolate 
induced metabolic effects and random forest regression was 
used to explore the descriptors for the oxidation susceptibility. 
Random forest analysis involves a build-in cross-validation that 
uses out-of-bag data (usually 30% of the samples). For 
classification, there are two ways to measure variable 
importance, mean decrease in classification accuracy and mean 
decrease in Gini index. These usually provide slightly different 
results, and there is no common agreement which one should be 
preferred. For regression, the corresponding performance 
measures are increase in mean square error and increase in node 
purity. The calculations were performed with the R (R 
Development Core Team 2008) program package randomForest 
(Liaw & Wiener 2002). 
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4 Results and discussion 
4.1 1H NMR SPECTRA OF N-ALKANES 
Alkyl chains are important structural units in many compounds, 
for example in lipids. Even though the structures of n-alkanes 
are simple, they yield quite complex spectra. This chapter 
presents the quantum mechanical spectral analyses of n-butane, 
n-pentane, n-hexane, n-heptane, and hexaenoic acid in 
chloroform. In addition, solvent effects on the conformational 
equilibrium of n-alkanes are discussed. 
4.1.1 Quantum mechanical spectral analysis of n-alkanes (I) 
The difficulty in the analysis of n-butane was that the spectrum 
(Figure 23A) does not contain much information about the 
geminal coupling constant, and thus, its accurate value cannot 
be obtained from the spectral analysis. This problem could be 
solved by estimating the value of the geminal coupling constant 
on the basis of the analysis of n-pentane spectrum since the 
values of other coupling constants did not depend significantly 
on the 2J coupling. The spectral parameters of n-butane in 
chloroform are shown in Table 9. 
The spectral analysis of the 1H NMR spectrum of n-pentane 
in chloroform (Figure 23B) was straightforward and all the 
spectral parameters could be determined (Table 9). The spectral 
analysis of n-hexane (Figure 23C) appeared to be more complex 
and there were problems with all the other coupling constants 
except 3J couplings. First, the small 5J and 6J couplings could not 
be solved unambiguously, and they were set to zero. Since these 
couplings and their variations can be assumed to be small, this 
approximation does not cause significant bias to other 
couplings. Second, the spectrum does not contain enough 
information about the 2J couplings since only their difference 
(2J2,2 - 2J3,3) seemed to be well defined. The 2J couplings also 
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correlated with 4J2,4’ and 4J2,4 couplings and linewidths. Thus, the 
analysis was performed by fixing the 2J couplings to the values 
that were estimated on the basis of the spectral analysis of 
n-pentane. Third, the 4J2,4’ and 4J2,4 couplings remained inaccurate 
since only their sum was rather well defined. The spectral 
parameters of n-hexane in chloroform are shown in Table 9. 
The challenge in the spectral analysis of n-heptane was the 
size of the spin system (A3A3’B2B2’C2C2’D2) that yields a lot of 
non-degenerate transitions whereas the spectrum (Figure 23D) 
contains only little details. The spectral analysis was simplified 
by including only 2J, 3J, and 4J coupling constants into the 
analysis. The spectral data was inadequate for the 3J3,4’ and 3J3,4 
couplings, and hence, the values of these coupling constants are 
not accurate. The chemical shifts and coupling constants of 
n-heptane in chloroform are shown in Table 9. 
 
Error analysis 
The error analysis of PERCH NMR Software (Laatikainen et 
al. 2011) yields confidence limits for the spectral parameters but 
they are too optimistic since the error analysis does not take into 
account all the uncertainties arising from lineshape, baseline, 
and resolution enhancement. To be able to estimate the real 
uncertainties of the coupling constants, some spectra of 
n-pentane were analyzed in different ways; by using a 
weighting function that decreases the predominance of the 
strong methyl signals, without weighting or by analyzing only 
the CH2 signals. The FID was also multiplied in different ways 
using window functions resulting in different lineshapes. These 
analyses suggested that the confidence limits for the the 3J, 4J, 5J, 
and 6J coupling constants are up to 0.02 Hz and for the 2J 
couplings they are ca. 0.10 Hz. 
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Figure 23. 1H NMR spectra (500 MHz) of n-butane (A), n-pentane (B), n-hexane (C), 
and n-heptane (D) in chloroform together with the chemical shifts of the assigned 
protons. The observed (OBS), calculated (CALC), and the difference of these two 
spectra (DIFF) are presented with black, dark grey, and light grey lines, respectively. 
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Table 9. Chemical shifts (ppm) and coupling constants (Hz) of n-butane, n-pentane, 
n-hexane, and n-heptane in chloroform (at 300 K). 
 
Parameter n-butane n-pentane n-hexane n-heptane
δ(CH3) 0.8870 0.8834 0.8844 0.8833
δ(CH3CH2) 1.2865 1.3033 1.2950 1.2967
δ(CH3CH2CH2) - 1.2456 1.2616 1.2539
δ(CH3CH2CH2CH2) - - - 1.2788
3J1,2 7.389 7.393 7.403 7.401
4J1,3 -0.207 -0.212 -0.229 -0.236
5J1,4 -0.047 -0.001 -b -b
6J1,5 - 0.044 -b -b
2J2,2 -13.200a -13.285 -13.283a -13.264c
3J2,3 6.118 5.922 5.935 5.803
3J2,3’ 8.664 9.173 9.169 9.167
4J2,4 - -0.339 -0.363 -0.433
4J2,4’ - -0.346 -0.285 -0.250
2J3,3 - -13.164 -13.193a -13.188c
3J3,4 - - 5.717 5.654
3J3,4’ - - 9.644 9.778
4J3,5 - - - -0.313
4J3,5’ - - - -0.212
2J4,4 - - - -13.094c
3J2,3’/3J2,3 1.42 1.55 1.54 1.58
3J3,4’/3J3,4   1.69 1.73
The estimates of the 90% confidence limits for the coupling constants are between 
0.02–0.10 Hz. 
aThe value of 2J coupling was kept fixed during the iteration; the value was 
estimated on the basis of the spectral analysis of n-pentane. 
bFor the spectra of n-hexane and n-heptane the 5J and 6J coupling constants were 
set to zero. 
cThe spectrum of n-heptane did not contain much information about 2J couplings, 
and thus, these values should be considered with some reservation. 
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Approximate analysis of n-alkane spectra 
In order to obtain accurate spectral parameters, the 
linewidths must be as narrow as possible to reveal all the fine 
structures from the spectrum. On the contrary, when 1H NMR 
spectra are measured for quantitative analyses the FIDs are 
usually multiplied with a window function that increases the 
signal-to-noise ratio, and at the same time, the linewidths are 
broadened. In our n-alkane analyses, the linewidths were 0.2–
0.5 Hz when in quantitative analysis they are more often 0.7–
1.0 Hz. 
The purpose of this approximate analysis was to test how 
well the spectrum can be described if some coupling constants 
are set to zero. To imitate the conditions in quantitative analysis, 
an n-pentane spectrum was prepared in which the linewidth 
was approximately 0.7 Hz. When all the coupling constants 
were included, the rrms fit was 0.45% (from maximum 
intensity). The elimination of only 6J, or both 5J and 6J coupling 
constants did not change the rrms value. When all the 4J, 5J, and 
6J coupling constants were set to zero, the rrms fit increased to 
0.55%. The ignorance of the coupling constants induced small 
changes to the 2J and 3J couplings. The values of the geminal 
coupling constants changed 0.01–0.12 Hz whereas the vicinal 
coupling constants changed up to 0.05 Hz. To conclude, the 
n-pentane spectrum could be described reasonably well even 
though the 4J, 5J, and 6J coupling constants were ignored, which 
simplifies the analysis. However, the ignorance of the couplings 
does not much reduce the simulation time of the spin system. 
4.1.2 Trans-gauche equilibrium of n-alkanes in chloroform (I) 
The 3J2,3’/3J2,3 and 3J3,4’/3J3,4 ratios provide information about the 
trans-gauche (t-g) equilibrium of C2-C3 and C3-C4 junctions, 
respectively. The 3J2,3’/3J2,3 ratios for n-butane, n-pentane, 
n-hexane, and n-heptane in chloroform (Table 9) suggest that the 
proportion of the t conformer is clearly lower in n-butane than 
in n-pentane but in n-pentane and n-hexane it is almost the 
same. In n-heptane, the proportion of the t conformer is slightly 
increased compared to n-pentane. The t/g ratios in C3-C4 
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junction for n-hexane and n-heptane (Table 9) propose that the 
proportion of the t conformer is higher in C3-C4 junctions than 
in C2-C3 torsions. All these observations are in accordance with 
the average trans conformer populations obtained with Monte 
Carlo simulations (Thomas et al. 2006). 
The four-bond 4J2,4’ and 4J2,4 coupling constants reflect the 
populations of the gauche+gauche+ (g+g+) helix in which the sum of 
these couplings should be even positive. Since the sums of 4J2,4’ 
and 4J2,4 couplings for n-pentane, n-hexane, and n-heptane are 
very similar (vary between -0.65 and -0.69 Hz), the proportion of 
g+g+ type conformations in chloroform is not varied significantly 
with the chain length. 
4.1.3 Solvent effects on conformational equilibrium (I) 
To find out how chemical environment affects the 
conformations of n-alkanes, the spectra of n-pentane and 
n-hexane were measured in different solvents (Tables 10 and 11). 
In the case of n-pentane, only DMSO seems to have a small 
effect on the conformational equilibrium; it favors the gauche 
conformer in C2-C3 torsion that can be seen from the decreased 
ratio of 3J2,3’/3J2,3 (Table 10). 
There is a bit more variation in the 3J2,3’/3J2,3 ratios of n-hexane 
than in n-pentane proposing that the chemical environment has 
slightly stronger effect on the conformational equilibrium of 
n-hexane. The 3J2,3’/3J2,3 ratios (Table 11) show that the proportion 
of the t conformer in C2-C3 junction is slightly increased in 
acetone, methanol, and hexane-d14 compared with chloroform 
(Table 9) but only hexane-d14 of these solvents favors the t 
conformation also in C3-C4 junction. Benzene favors the t 
conformation only in C3-C4 torsion compared with chloroform. 
As in n-pentane, DMSO is the only solvent that increases the 
proportion of the gauche conformers in n-hexane (Table 11). 
Also the four-bond coupling constants propose that the 
solvent effects are minor. The sums of 4J2,4’ and 4J2,4 of n-pentane 
and n-hexane are negative and almost equal in different solvents 
(vary from -0.63 to -0.69 Hz). Only in the case of n-hexane in 
hexane-d14 the sum of 4J2,4’ and 4J2,4 is slightly different (-0.39 Hz). 
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However, due to the uncertainties in the spectral analysis, these 
couplings should be considered with some reservation. Thus, 
these results suggest that none of the solvents used in this study 
favors the g+g+ helix. 
In summary, the chemical environment seems to have only 
small effects on the conformational equilibrium. Polar DMSO 
favors slightly the gauche conformations whereas hydrophobic 
hexane-d14 increases the proportion of the trans conformations. 
These observed solvent effects are probably caused by packing 
effects (Lounila et al. 1999). 
 
Table 10. Chemical shifts (ppm) and coupling constants (Hz) of n-pentane in different 
solvents. 
 
Parameter C6D6 CD2Cl2 acetone CD3OD CD3CN DMSO 
δ(CH3) 0.8738 0.8824 0.8772 0.8959 0.8869 0.8599
δ(CH3CH2) 1.2629 1.3049 1.3051 1.3207 1.3116 1.2778
δ(CH3CH2CH2) 1.2012 1.2479 1.2490 1.2619 1.2558 1.2247
3J1,2 7.395 7.395 7.401 7.410 7.402 7.393
4J1,3 -0.235 -0.213 -0.217 -0.211 -0.214 -0.200
5J1,4 0.004 0.001 0.001 -0.007 0.004 0.005
6J1,5 0.079 0.047 0.047 0.031 0.048 0.025
2J2,2 -13.349 -13.264 -13.290 -13.292 -13.265 -13.267
3J2,3 5.917 5.926 5.914 5.926 5.935 5.975
3J2,3’ 9.185 9.160 9.212 9.194 9.170 9.034
4J2,4 -0.372 -0.334 -0.337 -0.330 -0.342 -0.317
4J2,4’ -0.292 -0.342 -0.343 -0.342 -0.343 -0.348
2J3,3 -13.240 -13.138 -13.160 -13.158 -13.127 -13.135
3J2,3’/3J2,3 1.55 1.55 1.56 1.55 1.55 1.51
The estimates of the 90% confidence limits for the coupling constants are between 
0.02–0.10 Hz. 
C6D6, benzene; CD2Cl2, dichloromethane; CD3CN, acetonitrile; CD3OD, methanol; 
DMSO, dimethylsulfoxide 
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Table 11. Chemical shifts (ppm) and coupling constants (Hz) of n-hexane in different 
solvents. 
 
Parameter hexane-d14 C6D6 acetone CD3OD DMSO
δ(CH3) 0.8970 0.8862 0.8816 0.8973 0.8622
δ(CH3CH2) 1.3179 1.2700 1.3016 1.3132 1.2709
δ(CH3CH2CH2) 1.2884 1.2295 1.2722 1.2813 1.2421
3J1,2 7.423 7.402 7.453 7.437 7.376
4J1,3 -0.180 -0.234 -0.280 -0.235 -0.165
2J2,2a -13.285 -13.285 -13.285 -13.285 -13.285
3J2,3 5.830 5.939 5.894 5.870 6.089
3J2,3’ 9.065 9.151 9.227 9.190 8.831
4J2,4b 0.263 -0.159 -0.382 -0.292 -0.353
4J2,4’b -0.651 -0.519 -0.243 -0.341 -0.297
2J3,3a -13.150 -13.150 -13.150 -13.150 -13.150
3J3,4 5.335 5.585 5.735 5.785 5.654
3J3,4’ 9.727 9.711 9.650 9.652 9.610
3J2,3’/3J2,3 1.55 1.54 1.57 1.57 1.45
3J3,4’/3J3,4 1.82 1.74 1.68 1.67 1.70
The estimates of the 90% confidence limits for the coupling constants are between 
0.02–0.10 Hz. C6D6, benzene; CD3OD, methanol; DMSO, dimethylsulfoxide 
aThe 2J couplings were estimated on the basis of the spectral analysis of n-pentane 
and they were kept fixed during the iteration. 
bThe sum of 4J2,4’ and 4J2,4 is well defined but their difference is not, and therefore, 
the values should be considered with some reservation. 
4.1.4 Quantum mechanical spectral analysis of a short fatty 
acid 
Saturated FAs contain alkyl chains and their spectra resemble 
partly the spectra of n-alkanes. However, since FAs contain a 
carbonyl group, the chemical shifts of the CH2 protons are more 
separated than in n-alkanes. Figure 24 shows the 1H NMR 
spectrum of hexanoic acid in chloroform. The starting values for 
the analysis were estimated on the basis of the spectral analyses 
of n-alkanes, and it can be seen from Table 12 that the optimized 
coupling constants of hexanoic acid are very similar to those of 
n-alkanes (Table 9). 
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Figure 24. 1H NMR spectrum (500 MHz) of hexanoic acid in chloroform with signal 
assignments. The observed (OBS), calculated (CALC), and the difference of these two 
spectra (DIFF) are presented with black, dark grey, and light grey lines, respectively. 
 
Quantum mechanical spectral analysis slows down when the 
number of spin particles increases. For example, the spectral 
analysis of hexanoic acid can be performed within hours but for 
octanoic acid, that contains eight carbons, the analysis is 
remarkably slower. However, the increase of the analysis time is 
not the only challenge. When the alkyl chain is lengthened, there 
are more protons that resonate at 1.25–1.40 ppm, and it is 
difficult to obtain spectral parameters from these severely 
overlapping CH2 signals. Already the analysis of palmitoleic 
acid (16:1) took several days and all the 3J couplings and 
chemical shifts could not be defined. 
 
Table 12. Chemical shifts (ppm) and coupling constants (Hz) of hexanoic acid in 
chloroform. Naming of the protons is the same as in Figure 24. 
 
Parameter  Parameter  Parameter  
δ(a) 2.3034 3Ja,b’ 8.635 4Jb,d’ -0.329
δ(b) 1.6292 4Ja,c -0.289 2Jc,c -13.183
δ(c) 1.2997 4Ja,c’ -0.278 3Jc,d 5.920
δ(d) 1.3253 2Jb,b -13.488 3Jc,d’ 9.162
δ(e) 0.8972 3Jb,c 5.724 4Jc,e -0.191
2Ja,a -15.569 3Jb,c’ 9.783 2Jd,d -13.296
3Ja,b 6.529 4Jb,d -0.356 3Jd,e 7.375
The estimates of the 90% confidence limits for the coupling constants are between 
0.02–0.10 Hz. 
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4.2 1H NMR SPECTRA OF INDIVIDUAL LIPID SPECIES 
The lipid fraction of human serum consists of several different 
lipid species. 1H NMR spectra of some common serum FAs, 
glycerolipids, and sphingolipid, as well as free and esterified 
cholesterol are presented in Figures 25–27. 
 
 
 
Figure 25. 1H NMR spectra of palmitic acid (16:0), oleic acid (18:1 ω-9), palmitoleic 
acid (16:1 ω-7), linoleic acid (18:2 ω-6), dihomo-γ-linolenic acid (20:3 ω-6), 
arachidonic acid (20:4 ω-6), α-linolenic acid (18:3 ω-3), eicosapentaenoic acid (20:5 ω-
3), and docosahexaenoic acid (22:6 ω-3) in chloroform (500 MHz) with signal 
assignments. The boxes indicate the signals arising from (a) other PUFAs than linoleic 
acid, (b) linoleic acid, (c) docosahexaenoic acid, (d) monounsaturated fatty acids (FAs), 
(e) ω-3 FAs, (f) ω-6 FAs, and (g) ω-7,9, and saturated FAs. 
 
The ω-3 (0.97 ppm), ω-6 (0.89 ppm), and ω-7, ω-9, as well as 
SFAs (0.88 ppm) can be distinguished from the spectrum of a 
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lipid mixture on the basis of their methyl resonances (Figure 25). 
Linoleic acid and DHA can be directly quantified since they 
both have one distinguishable signal in the spectra of lipid 
mixtures. Other PUFAs than linoleic acid, except DHA, can be 
determined only as a sum since their signals arising from the 
bisallylic protons overlap at 2.8–2.9 ppm. The quantification of 
MUFAs is possible by using the quartet signal at 2.0 ppm arising 
from the protons attached to the carbons next to the double 
bond carbons (Figure 25). 
 
 
 
Figure 26. 1H NMR spectra of phosphatidylcholine (PC), sphingomyelin (SM), and 
triacylglyceride (TAG) in chloroform (500 MHz) with signal assignments. The 
characteristic signals for PC, SM, and TAG that can be used for their quantification 
from lipid mixtures are indicated with boxes. 
 
About half of the spectra of PC, SM, and TAG are composed 
of the signals from the FA chains (Figure 26). Lipids containing 
a choline group, such as PC and SM, have a characteristic singlet 
at approximately 3.3 ppm arising from three methyl groups. The 
most characteristic signal for SM is the one from a double bond 
proton at 5.7 ppm. TAGs and phosphoglycerides give signals 
from the glycerol backbone at 4.1–4.4 ppm that can be used for 
their quantification from a lipid mixture. 
1H NMR spectra of free and esterified cholesterol are 
presented in Figure 27. Free and esterified cholesterol can be 
easily identified by looking at the signals at 3.5 and 4.7 ppm 
arising from a proton attached to carbon-3 (Figure 5). The singlet 
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at 0.7 ppm from C(18)H3 protons is the best signal for the 
quantification of total cholesterol. 
 
 
 
Figure 27. 1H NMR spectra of free cholesterol (FC) and cholesteryl ester (CE) in 
chloroform (500 MHz) with some signal assignments. The numbering of the 
cholesterol protons is the same as in Figure 5. The characteristic cholesterol signals 
that can be used for their quantification from lipid mixtures are indicated with boxes. 
4.3 EXTRACTION PROTOCOL FOR SERUM LIPIDS 
The extraction protocol used in this study is based on the 
dichloromethane extraction method (Cequier-Sánchez et al. 
2008). Our aim was to optimize the extraction yield, as well as to 
enable the extraction of about 100 samples per day. 
The effect of different mixing methods, as well as the most 
effective way for the addition of the extraction solvents was 
tested. Four variations from the dichloromethane extraction 
protocol (methods 1–4 in Table 13) were performed and the 
results are presented in Figure 28. It appeared that the best 
yields are obtained by mixing at a vertical shaker or by using 
sonication. Vortexing seemed to be the less effective mixing 
method. Also, the addition of methanol dropwise and 
dichloromethane and sodium chloride solution slowly by a glass 
pipette did not increase the yield. Thus, all the extraction 
solvents can be added by pouring. 
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Table 13. Different variations from the extraction protocol. 
 
Method Extraction procedure 
1 - 5 ml CH3OH + 10 ml CH2Cl2 + 15 ml 0.15 M NaCl (all poured) 
- mixing at a vertical shaker 5 min, centrifugation 2400 × g 10 min, 
phase separation 
- 10 ml CH2Cl2 (poured) 
- mixing, centrifugation, and phase separation as in the previous step 
2 - 5 ml CH3OH (poured) + 10 ml CH2Cl2 (poured) 
- sonication 5 min 
- 15 ml 0.15 M NaCl (poured) 
- sonication 5 min, centrifugation 2400 × g 10 min, phase separation 
- 10 ml CH2Cl2 (poured) 
- sonication, centrifugation, and phase separation as in previous step 
3 - 5 ml CH3OH + 10 ml CH2Cl2 + 15 ml 0.15 M NaCl (all poured) 
- vortex 45 s, centrifugation 2400 × g 10 min, phase separation 
- 10 ml CH2Cl2 (poured) 
- vortex 45 s, centrifugation 2400 × g 10 min, phase separation 
4 - 5 ml CH3OH dropwise + 10 ml CH2Cl2 (with a glass pipette) + 15 ml 
0.15 M NaCl (with a glass pipette) under magnetic stirring 
- vortex 45 s, centrifugation 2400 × g 10 min, phase separation 
- 10 ml CH2Cl2 (with a glass pipette) 
- vortex 45 s, centrifugation 2400 × g 10 min, phase separation 
5 - 10 ml 1:2 CH3OH:CH2Cl2 mixture + 10 ml 0.15 M NaCl (all poured) 
 - mixing at a vertical shaker 5 min, centrifugation 2400 × g 10 min, 
phase separation 
 - 5 ml CH2Cl2 (poured) 
 - mixing, centrifugation, and phase separation as in the previous step 
 
 
108   
 
 
 
Figure 28. Signal areas (in area units) of the selected lipid species from the 1H NMR 
spectra of serum lipid extracts using different mixing methods. The numbering of the 
columns refers to the extraction procedures in Table 13. 18:2, linoleic acid; CE, 
cholesteryl ester; DB, double bond protons; FC, free cholesterol; PC, 
phosphatidylcholine; PG, phosphoglyceride; PUFAs, polyunsaturated fatty acids; SM, 
sphingomyelin; TAG, triacylglyceride; ω-3, ω-3 fatty acids; ω-6,7, ω-6 and ω-7 fatty 
acids; ω-9,sat, ω-9 and saturated fatty acids 
 
The repeatabilities of the extraction methods 1 and 2 (Table 
13) were examined by extracting three serum samples. As can be 
seen from Figure 29, the standard deviations are smaller when 
the samples are mixed at a vertical shaker. 
 
 
 
Figure 29. Average signal areas (in area units) and standard deviations of the selected 
lipid species from the 1H NMR spectra of serum lipid extracts calculated from 
triplicate samples. The numbering of the columns refers to the extraction procedures in 
Table 13. For the abbreviations, see Figure 28. 
 
To find out how many extraction steps are required to extract 
at least ca. 95% of the serum lipids, some serum samples were 
extracted using the extraction procedure 1 (Table 13) with three 
extraction steps. In each step, the dichloromethane phase was 
collected to a separate tube. Figure 30 illustrates that 80–90% of 
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the lipids are recovered in the first extraction step. The second 
step yields 7–13%, and only 0.3–6% of the lipids remains after 
two extraction steps. Thus, it can be concluded that two 
extraction steps are enough to extract 95–99% of the serum 
lipids. 
 
 
 
Figure 30. Extraction yields (%) of the selected lipid species after first, second, and 
third extraction. For the abbreviations, see Figure 28. 
 
Finally, it was tested whether methanol and dichloromethane 
could be combined since it would fasten the extraction 
procedure. The experiment showed that there is no remarkable 
difference between the extraction yields if the two solvents are 
combined or added separately (Figure 31). Thus, the extraction 
procedure 5 in Table 13 was selected to be the most efficient 
taking into account both the yield, as well as the speed. 
 
 
 
Figure 31. Signal areas (in area units) and standard deviations of the selected lipid 
species from the 1H NMR spectra of serum lipid extracts calculated from triplicates. 
The numbering of the columns refers to the extraction procedures in Table 13. For the 
abbreviations, see Figure 28. 
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4.4 QUANTIFICATION PROTOCOL FOR SERUM LIPIDS 
The 1H NMR spectra of complex lipid mixtures, such as serum, 
contain many closely located lines, and some of them can be 
strongly overlapping. Thus, the determination of signal areas by 
traditional integration methods from this kind of spectrum is 
difficult and more sophisticated methods are required. 
4.4.1 Constrained total-line-shape fitting 
Deconvolution is a method to determine signal areas by fitting 
lines under spectral signals (Laatikainen et al. 1996b). Each line 
has four parameters including frequency, width, intensity, and 
lineshape. These parameters are iterated to yield as good fit as 
possible. In order to get areas for signals that are formed from 
several lines, the lines are assorted into a group, called complex, 
so that the program automatically calculates the total area. The 
formation of complexes is especially important when the 
statistics of the areas is required (Soininen et al. 2005). 
If there is prior knowledge available for the signal structures 
or shapes, it is possible to use CTLS fitting method. In the CTLS, 
the structures of the multiplets are given in the form of linear 
equations for the total-line-shape fitting algorithm (Soininen et 
al. 2005). Then, the spectral parameters are iterated, enabling the 
CTLS algorithm to automatically adapt to small changes in the 
signal intensities and positions (Jukarainen et al. 2008). 
The constraints for the fitting can be defined in different 
ways. For example, it is possible to form a symmetric multiplet, 
e.g. a triplet with intensity ratio 1:2:1. The use of a multiplet 
structure minimizes the number of the parameters to be 
optimized since only the total intensity, the midpoint of the 
multiplet, usually only one splitting, and one linewidth are 
optimized instead of fitting many line positions, intensities, and 
linewidths (Soininen et al. 2005). In addition, it is possible to use 
“soft constraints” that include linear equations for signal 
positions, areas, intensities, and linewidths (Soininen et al. 2005; 
Jukarainen et al. 2008). For example, the linewidths of separate 
multiplets can be set equal. After defining the constraints, they 
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can be weighted. The less strict the rule, the smaller is the 
weight for the constraint. If absolutely strict constraints are 
needed, one can use a “structure” that is created by defining a 
list of spectral lines with characteristic positions, intensities, and 
linewidths (Jukarainen et al. 2008). During the iteration, the 
structure is exactly preserved, and only the relative intensities, 
positions, and linewidths of the lines constructing the structure 
are optimized. 
Commonly the fitting has to be performed in parts since the 
maximum number of parameters that can be simultaneously 
optimized for one spectral part is 500 (Jukarainen et al. 2008). 
The other reason for fitting in parts is that the baseline is usually 
not similar in each part of the spectrum. The number of lines 
and baseline function terms are chosen so that a good fit is 
obtained (i.e. there is only a small variation between the 
observed and calculated spectra) for each part to be fitted 
(Soininen et al. 2005). 
The aim of this subproject was to find out how well the 
NMR-based lipid concentrations and percentage values 
correspond to the values obtained by other methods. The 
samples from the chocolate study (Mursu et al. 2004) were 
suitable for this purpose since several lipid species were 
analyzed from the samples previously by GC or by an 
enzymatic colorimetric test. 
The constraints used in the CTLS analysis of the 1H NMR 
spectra of the lipid extract samples were built up on the basis of 
the model spectra (Figures 25–27). The spectra were fitted in 13 
parts, each of which independently. The spectral region of 0.84–
1.40 ppm is a good example of the use of different constraints 
since that area contains a lot of severely overlapping multiplets 
(Figure 32), and thus, forms a challenge for the quantification 
protocol. 
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Figure 32. A part of the 1H NMR spectrum of extracted serum showing the observed 
spectrum (black line), the fitted signals (colored lines), and the difference between the 
observed spectrum and the fitted signals (green line). 
 
In the CTLS fitting protocol, the methyl signal of the ω-3 FAs 
was defined as a triplet with intensity ratio 1:2:1. The coupling 
constant of the triplet was also set as a constraint. To prevent the 
signal from broadening, the linewidth was bound to the 
linewidth of the line from the ω-6 FA signal (Table 14). The 
methyl signals of the ω-6, ω-7, and ω-9 and SFAs were described 
with four lines (Figure 33), and their frequencies, linewidths, 
and intensities were defined with equations shown in Table 14. 
Several signals arising from free and esterified cholesterol at 
0.93–1.3 ppm were defined as structures (Figure 32). 
 
 
 
Figure 33. Construction of the methyl signals of the ω-6 (ω-6_1–4), ω-7 (ω-7_1–4), 
and ω-9 and saturated fatty acids (ω-9,SFA_1–4). 
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Table 14. Constraint equations and weighting factors used in the quantification of the 
signals arising from methyl protons of ω-3, ω-6, ω-7, and ω-9 fatty acids (FAs) and 
saturated fatty acids (SFAs). The numbering of the lines is the same as in Figure 33. 
 
Signal Parameter Equation Weight 
 Frequency 1.0 × ω-6_1 = 1.0 × ω-6_3 + 6.5950 99.0
 Frequency 1.0 × ω-6_2 = 1.0 × ω-6_3 + 0.2860 99.0
 Frequency 1.0 × ω-6_4 = 1.0 × ω-6_3 - 7.0470 99.0
 Width 1.0 × ω-6_1 = 0.3550 × ω-6_2 99.0
ω-6 FAs Width 1.0 × ω-6_3 = 0.2320 × ω-6_2 99.0
 Width 1.0 × ω-6_4 = 0.3010 × ω-6_2 99.0
 Intensity 1.0 × ω-6_1 = 0.4560 × ω-6_3 99.0
 Intensity 1.0 × ω-6_2 = 0.2450 × ω-6_3 99.0
 Intensity 1.0 × ω-6_4 = 0.5460 × ω-6_3 99.0
 Frequency 1.0 × ω-7_1 = 1.0 × ω-7_3 + 6.7270 99.0
 Frequency 1.0 × ω-7_2 = 1.0 × ω-7_3 + 4.4890 99.0
 Frequency 1.0 × ω-7_4 = 1.0 × ω-7_3 - 6.9680 99.0
 Width 1.0 × ω-7_1 = 0.4110 × ω-7_2 99.0
ω-7 FAs Width 1.0 × ω-7_3 = 0.3730 × ω-7_2 99.0
 Width 1.0 × ω-7_4 = 0.4830 × ω-7_2 99.0
 Intensity 1.0 × ω-7_1 = 0.2960 × ω-7_3 99.0
 Intensity 1.0 × ω-7_2 = 0.1770 × ω-7_3 99.0
 Intensity 1.0 × ω-7_4 = 0.4370 × ω-7_3 99.0
 Frequency 1.0 × ω-9,SFA_1 = 1.0 × ω-9,SFA_3 + 6.7760 99.0
 Frequency 1.0 × ω-9,SFA_2 = 1.0 × ω-9,SFA_3 + 4.9610 99.0
 Frequency 1.0 × ω-9,SFA_4 = 1.0 × ω-9,SFA_3 - 7.0590 99.0
ω-9 & Width 1.0 × ω-9,SFA_1 = 0.3710 × ω-9,SFA_2 99.0
SFAs Width 1.0 × ω-9,SFA_3 = 0.3330 × ω-9,SFA_2 99.0
 Width 1.0 × ω-9,SFA_4 = 0.3910 × ω-9,SFA_2 99.0
 Intensity 1.0 × ω-9,SFA_1 = 0.3130 × ω-9,SFA_3 99.0
 Intensity 1.0 × ω-9,SFA_2 = 0.1230 × ω-9,SFA_3 99.0
 Intensity 1.0 × ω-9,SFA_4 = 0.4410 × ω-9,SFA_3 99.0
 Width 1.0 × ω-3 = 1.0 × ω-6_3 10.0
 Width 1.0 × ω-9,SFA_3 = 1.2130 × ω-6_3 10.0
 Width 1.0 × ω-7_3 = 1.210 × ω-9,SFA_3 10.0
 Splitting 1.0 × ω-3 = 7.50 10.0
 Frequency 1.0 × ω-7_3 = 1.0 × ω-9,SFA_3 + 1.3642 1.0
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The percentage values and concentrations of various lipids 
determined by CTLS were compared with the corresponding 
measures determined by an enzymatic colorimetric test (TAGs) 
or by GC (FAs) in the chocolate study (Mursu et al. 2004) 
(Figures 34 and 35). To change the signal areas obtained from 
the NMR spectra into absolute concentrations, the signal areas 
were scaled using the total cholesterol concentration determined 
from the native serum by an enzymatic colorimetric test. 
 
 
 
Figure 34. The percentage values of several fatty acid (FA) variables determined both 
by NMR (y-axis) and gas chromatography (x-axis). Pearson’s or Spearman’s 
correlation coefficients (r) are shown for each variable. All the correlations are 
statistically significant (p < 0.001). The grey line describes the situation in which the 
values determined by the two different methods are equal. 18:2 FA, linoleic acid; 22:6 
FA, docosahexaenoic acid; MUFA, monounsaturated FA; PUFA, polyunsaturated FA; 
SFA, saturated FA 
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Figure 35. The concentrations (mM) of several fatty acid (FA) variables determined 
both by NMR (y-axis) and gas chromatography or, in the case of triacylglycerides 
(TAGs), an enzymatic colorimetric test (x-axis). Pearson’s or Spearman’s correlation 
coefficients (r) are shown for each variable. All the correlations are statistically 
significant (p < 0.001). The grey line describes the situation in which the values 
determined by the two different methods are equal. 18:2 FA, linoleic acid; 22:6 FA, 
docosahexaenoic acid; MUFA, monounsaturated FA; PUFA, polyunsaturated FA; 
SFA, saturated FA 
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Figure 35 shows that the TAG concentrations determined by 
NMR compare well with the concentrations obtained by an 
enzymatic colorimetric test (Spearman’s correlation 0.960, 
p < 0.001). The concentrations of total FAs obtained by NMR are 
approximately 50% higher than those determined by GC 
(Figure 35). This difference can be partly due to the fact that 
some FAs that are present in serum in small amounts were not 
included into the GC analysis. However, the values obtained by 
these two methods correlate strongly (Figure 35). 
Two individual FAs, linoleic acid and DHA, can be 
quantified directly from the 1H NMR spectrum of the extracted 
serum. The NMR-based absolute concentrations for linoleic acid 
are higher than those determined by GC (Figure 35). However, 
the percentage values (Figure 34) are in good agreement 
(Pearson’s correlation coefficient 0.975, p < 0.001). For DHA, the 
concentration values obtained by NMR and GC are quite similar 
(Pearson’s correlation 0.876, p < 0.001) but the NMR-derived 
percentage values are a bit smaller than those determined by GC 
(Spearman’s correlation 0.843, p < 0.001). 
The NMR-based absolute concentrations for total ω-6 and ω-3 
FAs are slightly higher than the corresponding GC values 
(Figure 35). The percentage values of ω-6 FAs are very similar 
(Figure 34) and the correlation is strong (Pearson’s correlation 
0.973, p < 0.001). NMR gives lower percentage values for ω-3 
FAs than GC but there is still quite strong correlation between 
the values (Spearman’s correlation 0.916, p < 0.001). 
The ω-7 FAs and ω-9 and SFAs give methyl resonances close 
to each other and there are also other resonances overlapping 
them (Figure 32) which makes their fitting challenging. The 
500 MHz spectrum does not have enough information for the 
reliable quantification of the ω-7 FAs separately, and thus, in the 
results, the amount of ω-7 FAs and ω-9 and SFAs are combined. 
The sum of the concentrations of ω-7, ω-9 and SFAs correlates 
well with the sum of corresponding FAs obtained by GC 
analysis (Spearman’s correlation 0.917, p < 0.001), and the 
correlation between their percentage values is even stronger 
(Pearson’s correlation 0.966, p < 0.001). 
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PUFAs that have more than two double bonds have different 
amounts of bisallylic protons, and this piece of information is 
used to calculate the concentration of other PUFAs than linoleic 
acid. The value representing the average number of bisallylic 
protons in serum PUFA pool excluding linoleic acid is six, and it 
could be estimated using the average concentrations of various 
PUFAs presented in Table 2. The percentage values of MUFAs, 
other PUFAs than linoleic acid, and all PUFAs determined both 
by NMR and GC are almost equal and they correlate strongly 
(Figure 34). When looking at the concentration values, the NMR 
method yields a bit higher concentrations for all these. 
The amount of SFAs cannot be directly obtained from the 1H 
NMR spectrum of the serum lipid extract but it can be 
calculated by subtracting the percentage values of MUFAs and 
PUFAs from 100%. Most of the NMR and GC derived 
percentage values for SFAs are quite similar but the dispersion 
of the values lowers the correlation (Spearman’s correlation 
0.779, p < 0.001). The correlation for the concentration values is 
higher (Spearman’s correlation 0.840, p < 0.001) but the NMR 
method yields again higher values compared with GC 
(Figure 35Figure 34). 
In general, the correlations between the percentage values are 
higher than the correlations between the absolute 
concentrations. The biggest variations in the percentage values 
are in the values of DHA and ω-3 FAs which are present in 
serum in low amounts. The extraction protocols used for GC 
(Mursu et al. 2004) and NMR samples were slightly different 
and may have caused different yields that can be seen in the 
amounts of total FA concentrations. By using GC method, it is 
possible to obtain absolute concentrations and percentage 
values for several individual FAs whereas NMR can separate 
only DHA and linoleic acid and the others are obtained as sums. 
However, to get reliable results, the GC method requires a 
standard compound for each FA to be measured and also 
calibration of the equipment, and thus, the GC method is more 
time consuming when compared with NMR. 
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4.5 NMR OXIDATION PROTOCOL (IV) 
The objective of this project was to develop a method to study 
the oxidation susceptibility of serum lipids by 1H NMR 
spectroscopy. Previously, NMR spectroscopy has been applied 
to study lipid peroxidation of LDL (Lodge et al. 1993; Lodge et 
al. 1995; Corso et al. 1997; Soininen et al. 2007). However, an 
NMR-based oxidation method for the lipids from whole serum 
is lacking. 
4.5.1 Development and optimization of the NMR oxidation 
assay 
PUFAs are prone to oxidation, and thus, the oxidation reaction 
can be followed from a 1H NMR spectrum of extracted serum by 
looking at the signals arising from the bisallylic protons of 
PUFAs at 2.74–2.88 ppm that decrease when the oxidation 
reaction proceeds (Figure 36). In developing the oxidation 
protocol, several copper concentrations and incubation times 
were tested. The oxidation reaction is rapid with copper 
concentrations of 1–4 mM whereas the copper concentration of 
0.5 mM provides milder oxidation conditions and the oxidation 
proceeds slower (Figure 37A). The largest variance between the 
percentage values describing the amount of oxidized PUFAs 
appeared to be at the time point of six hours (Figure 37B). 
Furthermore, at this point, the speed of the oxidation reaction 
has slowed down which allows slight differences in the 
incubation times without affecting the results. Oxidation of five 
replicate samples from three subjects (Figure 37B) proved that 
the NMR oxidation protocol yields repeatable results (standard 
deviations vary between 0.4 and 4.3 percentage units). 
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Figure 36. A 1H NMR spectrum of extracted serum with signal assignments (A). 
Some essential parts of the spectra (B–E) before (REF) and after (OX) the oxidation are 
shown at the top of the figure. CE, cholesteryl ester; FA, fatty acid; FC, free cholesterol; 
PC, phosphatidylcholine; PG, phosphoglyceride; sat, saturated; PUFA, 
polyunsaturated fatty acid; TC, total cholesterol; TAG, triacylglyceride 
 
 
 
 
Figure 37. The amounts of oxidized PUFAs during the copper induced oxidation with 
four different copper concentrations (A) and with a copper concentration of 0.5 mM 
for three subjects (B). Each data point in (B) is a mean of five determinations. 
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4.5.2 Comparison of the NMR oxidation assay with 
commonly used oxidation method 
The oxidation susceptibility of serum lipids has been commonly 
determined with a spectrophotometric method in which the 
oxidation reaction is initiated with copper. Oxidation leads to 
the formation of conjugated dienic hydroperoxides that absorb 
in the UV range, and thus, the reaction can be monitored 
spectrophotometrically (Schnitzer et al. 1998; Spranger et al. 
1998; Delimaris et al. 2007). The result is usually expressed as 
the lag time preceding oxidation that describes the time before 
the maximal reaction rate of diene accumulation has been 
reached (Delimaris et al. 2008). If a sample is very susceptible to 
oxidation, the lag time is short. By using the NMR method, this 
is seen as a high amount of oxidized PUFAs. 
Figure 38A shows that the baseline and end-point oxidation 
susceptibility values determined by 1H NMR correlate strongly 
with the corresponding lag time values obtained 
spectrophotometrically. However, even though the baseline and 
end-point values of these two methods correlate, the change 
values (end-baseline) do not have a correlation (Figure 38B). 
 
 
 
Figure 38. A) The amounts of oxidized PUFAs after the copper induced oxidation 
determined by the NMR oxidation method plotted against the corresponding lag time 
values obtained spectrophotometrically from the chocolate study samples. The 
regression line is y = -0.2665x + 100.4, r = 0.825. B) The end-baseline NMR oxidation 
values (ΔNMROX) plotted against the corresponding lag time values (ΔLag time). 
The regression line is y = 0.0462x + 2.3803, r = 0.158. 
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The different settings of the NMR and spectrophotometric 
assays explain, at least to some extent, the different results 
obtained with these two methods. Firstly, the NMR method 
observes the overall oxidation reaction considering both the 
early and later stages of the reaction whereas the 
spectrophotometric assay focuses only on the early stages of the 
oxidation reaction. Secondly, different incubation temperatures 
(37°C for the NMR protocol and 30°C for the spectrophotometric 
method) can affect the kinetics of the oxidation reaction as has 
been shown previously (Ramos et al. 1995). There are also 
different copper-to-serum ratios (0.5 mM/300 μl for the NMR 
method and 0.05 mM/13.4 μl for the spectrophotometric assay) 
which may have some effect on the oxidation reactions. Thirdly, 
there are no disturbing signals in the 1H NMR spectrum 
overlapping with the signals arising from PUFAs whereas in the 
spectrophotometric assay also albumin and some oxysterols 
absorb at the same wavelength as conjugated dienes (Schnitzer 
et al. 1998). 
4.6 APPLICATION OF THE NMR LIPID ANALYSIS TO CLINICAL 
STUDIES 
4.6.1 Lipid abnormalities in MCI (II) 
MCI is a neuropsychological diagnosis indicating severely 
increased risk for AD. There is evidence suggesting that 
systemic metabolite and lipid levels are associated with the 
development of AD (Shobab et al. 2005; Kivipelto & Solomon 
2006). The purpose of this study was to find new molecular 
insights on the potential early changes in systemic metabolism 
that relate to MCI, and thus, to high risk for AD. 
The self-organizing map (SOM) analysis used in this study 
was based on the combination of the three spectra that were 
measured from each serum sample (1H NMR spectrum of native 
serum revealing information about lipoprotein subclasses, T2 
edited 1H NMR spectrum of native serum yielding 
concentrations of low-molecular-weight metabolites, and 1H 
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NMR spectrum of extracted serum that gives information about 
different serum lipids). According to the analysis, the MCI 
samples cluster on the southeast part of the SOM (p < 0.05) 
(Figure 39) suggesting that there is a link between systemic 
metabolism and MCI. However, the distribution of MCI samples 
is not inclusive which probably reflects the complex link 
between the serum biochemistry and cognitive decline, as well 
as potentially various differing biochemical pathways behind 
MCI. This is also supported by the analyses at individual time 
points since none of the serum metabolites showed statistically 
significant changes between the control and MCI groups or 
between the different time points. Nevertheless, the holistic 
SOM analysis based on the multi-metabolite information in the 
1H NMR spectra of serum did define statistically significant 
metabolic associations for the MCI, indicating that the combined 
changes of several metabolites can be descriptive while the 
changes in the individual metabolites are not. 
Diabetes and obesity (high BMI) have been associated with 
MCI (Martins et al. 2006), and this was recognized also in this 
study since all these three conditions have quite similar color 
distributions in the SOM (Figure 39). Thus, the NMR data 
reveals the link between vascular factors and cognitive decline 
and a risk for dementia. 
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Figure 39. Statistical colorings of the clinical and biochemical variables in the self-
organizing map (SOM) analysis including 176 serum samples. Due to the SOM 
analysis the samples are positioned so that the multi-metabolite differences between 
nearby samples are minimized. Acyl groups, total amount of -CH3 groups in serum 
lipids; BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; LDL-C, 
low-density lipoprotein cholesterol; MCI, mild cognitive impairment; PC, 
phosphatidylcholine; SM, sphingomyelin; TC, serum total cholesterol; TAG, serum 
triacylglycerides; ω-3 absolute, the absolute amount of serum ω-3 fatty acids; ω-3 
relative, the ratio of ω-3 fatty acids and total fatty acids; ω-6 relative, the ratio of ω-6 
fatty acids and total fatty acids 
 
Serum cholesterol has been suggested to be a risk factor for 
AD (Shobab et al. 2005; Kivipelto & Solomon 2006). Here, the 
highest total cholesterol values concentrate on the northeast 
corner of the SOM (Figure 39). The LDL cholesterol values 
follow the total cholesterol with only slight differences. It is also 
notable that the low HDL cholesterol clearly associates with 
high TAGs in the southeast corner suggesting that there is an 
association between the metabolic syndrome and MCI. Thus, 
within the current limited data set, it appears that metabolic 
syndrome would be more associated with MCI than high total 
cholesterol as such. 
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Since cholesterol and TAGs are abundant in serum and they 
contain acyl groups (except free cholesterol) it is logical that the 
highest amounts of acyl groups are found from the samples that 
have a lot of cholesterol or TAGs (Figure 39). The lowest 
absolute concentrations of ω-3 FAs concentrate on the western 
side of the SOM whereas the lowest relative amounts of ω-3 FAs 
coincide remarkably well with MCI in the southeast corner of 
the map. These results suggest that a low relative amount of ω-3 
FAs would be more indicative of high risk for AD than low 
serum ω-3 concentration as such (Martins et al. 2006). 
It has been suggested that serum sphingomyelin may be a 
good pre-clinical predictor of memory impairment (Mielke et al. 
2010). In this study, the highest amounts of sphingomyelin and 
PC concentrate on the northeast corner of the SOM, similarly 
with total cholesterol (Figure 39). The lowest amounts of 
sphingomyelin cluster on the southeast corner and overlap with 
MCI samples (Figure 39). 
To conclude, the application in cognitive impairment 
suggests that systemic lipid metabolism, especially the 
metabolic syndrome and the relative amount of serum ω-3 FAs, 
has a distinct role in the risk assessment of AD. The results from 
this pilot study also justify more extensive applications of serum 
NMR metabonomics in neurological disorders. 
4.6.2 Lipid abnormalities in type 1 diabetic patients having 
kidney disease (III) 
Diabetic kidney disease is a symptom of chronic vascular injury 
in diabetes and it is associated with dyslipidemia and increased 
mortality. The aim of this study was to find out which lipid 
variables are related with diabetic kidney disease. 
The univariate logistic regression analysis revealed that 
sphingomyelin and large HDL lipids have the strongest 
association with diabetic kidney disease and only commonly 
known biomarkers such as serum creatinine, serum cystatin-C, 
serum urea, and glomerular filtration rate have higher 
regression coefficients (Figure 40). Also various lipids of large 
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and extra large VLDL particles are related with kidney disease. 
(Figure 40) 
Since 24 h-AER values describe the continuous renal status, 
also correlations between lipid variables and 24 h-AER were 
studied. Sphingomyelin has the largest correlation coefficient 
but also TAGs, large VLDL cholesterol, large HDL cholesterol, 
and HDL cholesterol have strong correlations (Table 15). 
Sphingomyelin, TAGs, and large VLDL cholesterol are directly 
correlated with 24 h-AER, whereas large HDL cholesterol and 
HDL cholesterol are inversely correlated (Table 15). 
 
 
 
Figure 40. Odds ratios for diabetic kidney disease (adjusted by diabetes duration, age, 
and gender). The circles indicate logarithmic odds ratios (regression coefficients in the 
logistic model) and the horizontal lines show the 95% interval. The fold change was 
calculated by dividing the median concentration difference (after adjustments) between 
the cases and controls by the median concentration in the control group. Only those 
variables that reached Bonferroni multiple testing significance are included 
(p < 0.00038). 
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Table 15. Lipid variables that are significantly correlated with 24 h-AER. 
 
 Adjusted  Unadjusted 
 Correlation p  Correlation p 
Sphingomyelin 0.42 1.5×10-14  0.43 6.7×10-16 
TAGs 0.30 3.7×10-7  0.38 1.6×10-10 
Large VLDL cholesterol 0.30 1.2×10-7  0.29 1.4×10-7 
Free cholesterol 0.29 3.0×10-7  0.32 9.2×10-9 
ω-9 and sat FAs 0.26 3.3×10-6  0.33 1.8×10-9 
ω-6 and ω-7 FAs 0.26 5.3×10-6  0.26 4.3×10-6 
IDL TAGs 0.22 0.00011  0.27 1.8×10-6 
Phosphoglycerides 0.12 0.036  0.16 0.0041 
PC -0.02 0.71  0.00 0.96 
ω-3 FAs -0.05 0.39  -0.03 0.60 
FA length -0.20 0.00040  -0.25 6.6×10-6 
Medium HDL cholesterol -0.25 1.2×10-5  -0.28 5.7×10-7 
HDL cholesterol -0.31 2.1×10-7  -0.27 4.9×10-6 
Large HDL cholesterol -0.33 3.6×10-9  -0.32 7.7×10-9 
Correlation was measured by the Spearman coefficient and the Bonferroni multiple 
testing limit is at p < 0.00038. 
FA, fatty acid; HDL, high-density lipoprotein; IDL, intermediate-density 
lipoprotein; PC, phosphatidylcholine; sat, saturated; TAG, triacylglyceride; VLDL, 
very-low-density lipoprotein 
 
Multivariate linear regression was used to explain the 
covariance between sphingomyelin and 24 h-AER. For this 
purpose, two sets of variables were chosen. Set 1 included 
sphingomyelin, duration of type 1 diabetes, metabolic 
syndrome, glomerular filtration, and glucose disposal rate 
(Table 16). Set 2 involved measures that are diagnostic for some 
disease states. For example, blood pressure is associated with 
hypertension and TAGs and HDL cholesterol are related to 
dyslipidemia (Table 16). Sphingomyelin was shown to be a 
statistically significant variable in both models (Table 16) 
suggesting that sphingomyelin has an important role in 
albuminuria. 
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Table 16. Regression coefficients for the two models of 24 h-AER. 
 
Model 1 Beta p   Model 2 Beta p 
Sphingomyelin 0.22 1.8×10-5   Sphingomyelin 0.22 1.1×10-5 
T1DM duration 0.011 0.42   T1DM duration 0.19 0.00013 
MetS 0.12 0.0042   Male gender 0.0012 0.50 
eGDR -0.32 1.4×10-10   Waist 0.057 0.173 
eGFR -0.28 5.6×10-6   Systolic BP 0.087 0.047 
     Hemoglobin A1c 0.15 0.0011 
     TAGs 0.031 0.33 
     HDL cholesterol -0.13 0.0046 
     Creatinine 0.30 7.8×10-6 
Models 1 and 2 explained 44.1 and 41.9% of 24 h-AER variance, respectively. 
Without sphingomyelin the explanation percentages were 40.5 and 38.8, 
respectively. AER, urinary albumin excretion rate; BP, blood pressure; eGDR, 
efficient glucose disposal rate; eGFR, estimated glomerular filtration rate; HDL, 
high-density lipoprotein; MetS, Metabolic syndrome; T1DM, type 1 diabetes 
mellitus; TAG, triacylglyceride 
 
A recent animal study supports the role of sphingomyelin in 
kidney disease. In the study, untreated mice on a high-fat diet 
developed insulin resistance and albuminuria but the inhibition 
of the conversion of sphingomyelin into ceramide significantly 
decreased glomerular injury and restored AER to normal range 
(Boini et al. 2010). 
It is also possible that excess circulating sphingomyelin is a 
by-product of the disease process and not an initiator. In fact, 
excess SFAs may be the underlying cause since SFAs are 
substrates for sphingolipid synthesis. SFAs promote lipotoxicity 
through the production of ceramides and they are also linked to 
insulin resistance (Kennedy et al. 2009; Yang et al. 2009; Bunn et 
al. 2010). The correlations between the sum of ω-9 and saturated 
FAs and kidney disease (Figure 40) and 24 h-AER (Table 15) 
support this view. 
In conclusion, sphingomyelin was shown to be associated 
both with diabetic kidney disease and AER. The results are 
supported by animal data, which suggests that sphingolipids 
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may reflect some of the molecular links between microvascular 
injury, insulin resistance, and SFAs. Further research is required 
to confirm the role of sphingomyelin in diabetic kidney disease. 
4.7 APPLICATION OF THE NMR OXIDATION ASSAY TO 
CHOCOLATE STUDY SAMPLES (IV) 
The NMR oxidation assay was applied to fasting serum samples 
from the chocolate study. The oxidation susceptibility of serum 
lipids decreased in the HPC group (p = 0.016) after the chocolate 
consumption but there were no significant changes in the DC 
(p = 0.407) or WC (p = 0.758) groups. The change in the NMR 
oxidation susceptibility was significantly different between the 
WC and HPC groups (p = 0.031). Since the baseline values of the 
HPC group are lower than in the WC and DC groups (Table 17), 
the analyses were also performed by adjusting the baseline 
values of the variables but the changes between the groups were 
significantly different also after the adjustment (p = 0.043). 
Interestingly, statistically significant changes between the study 
groups were not observed when the oxidation susceptibility was 
determined using the spectrophotometric method (Table 17) 
(Mursu et al. 2004). 
 
Table 17. The NMR oxidation susceptibility and the lag time before (baseline) and 
after (change) the consumption of the study chocolates. 
 
Parameter  NMR oxidation susceptibility (%) Lag time (min)
WC 
Baseline 72 ± 14 118 ± 43 
Change 0 ± 5 6 ± 31 
DC 
Baseline 71 ± 10 122 ± 35 
Change -2 ± 8 4 ± 32 
HPC 
Baseline 64 ± 17 160 ± 61 
Change 7 ± 10 -3 ± 28 
p  0.033 0.711 
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4.7.1 Determinants of oxidation susceptibility 
Random forest regression was used to find out if there is a set of 
variables that would explain the differences in the NMR 
oxidation susceptibility values. The variables included into the 
analyses consisted of previously measured variables (Mursu et 
al. 2004) and a total of 23 lipid variables obtained by NMR. The 
previously measured variables involved several FAs and other 
lipid measures, some common serum parameters such as 
hemoglobin and hematocrit, as well as vitamins and 
polyphenols. 
The analysis included the baseline and end-point values of 
the variables described above. Random forest regression was 
able to explain 60% of the NMR oxidation susceptibility values 
with nine variables, and most of them are lipid measures (Figure 
41). According to the variable importance measures, arachidonic 
acid and DHA are the most important determinants of NMR 
oxidation susceptibility (Figure 41). This is logical since the 
NMR oxidation protocol measures the amount of oxidized 
PUFAs. 
 
 
Figure 41. Increase in mean square error (IncMSE) 
(%) and increase in node purity (Inc node purity) 
values for each variable obtained from the random 
forest regression when modeling the oxidation 
susceptibility values. 20:4 ω-6 FA, arachidonic acid; 
DHA, docosahexaenoic acid; FA, fatty acid; γ-GT, 
gamma-glutamyl transferase; HDL-C, high-density 
lipoprotein cholesterol; PC, phosphatidylcholine; PL, 
phospholipid 
 
 
Previously, vitamin C, urate, α-tocopherol, albumin, and 
HDL concentration have been proposed to be determinants of 
oxidation susceptibility (Nyyssönen et al. 1997). HDL 
cholesterol was also among our descriptors. Our data included 
also vitamin C and α-tocopherol values that were calculated 
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based on a 4 day food record but they were not regarded as 
determinants of oxidation susceptibility. However, considering 
that our data lacked serum urate and albumin concentrations, 
the explanation percentage of the model trying to explain the 
NMR oxidation susceptibility values (60%) is quite high. 
4.7.2 Lipid changes induced by the chocolate consumption 
The study chocolates had similar amounts of FAs, excluding 
behenic acid, but the amounts of cocoa and polyphenols were 
different. The main difference between the DC and HPC 
chocolates was the amount of polyphenols; HPC chocolate 
contained approximately 1.5 times more polyphenols than the 
DC chocolate. 
The random forest method allowed clustering of the WC, DC, 
and HPC groups with six variables (Figure 42). The analysis 
included the change (end-baseline) values of the variables 
described above. Behenic acid was excluded from the analysis 
since the HPC chocolate contained ten-fold amount of behenic 
acid compared with other study chocolates. 
 
 
 
Figure 42. Random forest clustering was obtained with six end-baseline variables. The 
variable importance measures, mean decrease in accuracy and mean decrease in Gini 
index, are shown for each of these variables. D, dark chocolate; DHA, docosahexaenoic 
acid; FA, fatty acid; HDL-C, high-density lipoprotein cholesterol; P, high-polyphenol 
chocolate; PC, phosphatidylcholine; SM, sphingomyelin; W, white chocolate 
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All the clustering variables are lipid measures (Figure 42) and 
three of them are same as those obtained by random forest 
regression (Figure 41). It seems that the consumption of the HPC 
chocolate induces different changes to the amounts of HDL 
cholesterol, nervonic acid, DHA, PC, sphingomyelin, and 
myristic acid than the consumption of the WC or DC chocolates 
as can be seen from the variable profiles (Figure 43). Since the 
main difference between the study chocolates was the amount 
of polyphenols, it is likely that they have induced the metabolic 
changes in the HPC group. However, on the grounds of this 
study it is impossible to identify the mechanisms of action. 
 
 
 
Figure 43. The profiles of the variable changes for the white chocolate (white), dark 
chocolate (light grey), and high-polyphenol chocolate (dark grey) groups. The values 
are expressed as standard deviation units from the mean of the whole study population. 
DHA, docosahexaenoic acid; FA, fatty acid; HDL-C, high-density lipoprotein 
cholesterol; PC, phosphatidylcholine; SM, sphingomyelin 
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5 Conclusions and future 
aspects 
In the present study, NMR protocols for analysis of serum lipids 
were developed and assessed. 
Quantum mechanical spectral analyses of 1H NMR spectra of 
n-alkanes were performed to be able to understand the 
conformational behavior of CH2-fragments, common structural 
units in lipids, in a solution state. According to the coupling 
constant information, the proportion of the trans conformation 
increases when the hydrocarbon chain is lengthened (Paper I). 
Chemical environment was shown to have only minor effects on 
the conformational equilibrium (Paper I). Quantum mechanical 
spectral analysis was also performed for a short fatty acid, and 
its spectral parameters greatly resembled those of n-alkanes. 
We developed an assay that allows the extraction of lipids 
from about 100 serum samples in a day, as well as a constrained 
total-line-shape fitting method for the quantification of lipids 
from the 1H NMR spectra of serum lipid extracts. The lipid 
analysis protocol was applied to two clinical studies. The results 
from the study involving patients with MCI revealed that a low 
relative amount of ω-3 FAs is more indicative of MCI than low 
serum ω−3 concentration as such (Paper II). The other study, 
involving type 1 diabetic patients, indicated that sphingomyelin 
is associated with kidney disease in type 1 diabetic patients 
(Paper III). 
Also, an NMR-based oxidation method for serum lipids was 
developed and the protocol was applied to serum samples from 
a dietary intervention. The results showed that the consumption 
of high-polyphenol chocolate decreased the oxidation 
susceptibility of serum lipids (Paper IV). This could not be 
detected by using the conventional spectrophotometric method, 
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even though the values obtained by these two oxidation 
methods correlated (Paper IV). 
So far, NMR lipid analysis has been used in several clinical 
studies covering various disease states such as subclinical 
atherosclerosis (Würtz et al. 2011; Würtz et al. 2012), 
cardiovascular disease (International Consortium for Blood 
Pressure Genome-Wide Association Studies 2011), and 
metabolic syndrome (Vanhala et al. 2012), as well as in studies 
dealing with associations of human serum metabolite levels and 
genetic loci (Inouye et al. 2010; Chambers et al. 2011; Kettunen et 
al. 2012; Tukiainen et al. 2012). In the future, one aim is to 
further optimize the protocol to decrease solvent consumption 
and to be able to increase the number of lipid measures obtained 
from a spectrum. Regarding the NMR oxidation assay, it would 
be interesting to apply this method to clinical studies in order to 
explore the applicability of the assay in assessing the oxidation 
susceptibility of serum lipids in disease states. 
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To deepen our understanding of 
the complex human lipid metabo-
lism, simple, fast, and cost-effective 
methods to study the serum lipid 
profile are needed. This thesis pre-
sents a nuclear magnetic resonance 
(NMR) spectroscopy -based high-
throughput method for the quan-
tification of serum lipids, as well 
as a protocol to study the oxidation 
susceptibility of serum. The applica-
tions of the developed methods to 
clinical and nutritional studies are 
also discussed.
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